<SEC-DOCUMENT>0000947871-23-000513.txt : 20230502
<SEC-HEADER>0000947871-23-000513.hdr.sgml : 20230502
<ACCEPTANCE-DATETIME>20230502170516
ACCESSION NUMBER:		0000947871-23-000513
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		6
FILED AS OF DATE:		20230502
DATE AS OF CHANGE:		20230502
EFFECTIVENESS DATE:		20230502

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CVS HEALTH Corp
		CENTRAL INDEX KEY:			0000064803
		STANDARD INDUSTRIAL CLASSIFICATION:	RETAIL-DRUG STORES AND PROPRIETARY STORES [5912]
		IRS NUMBER:				050494040
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-271582
		FILM NUMBER:		23880266

	BUSINESS ADDRESS:	
		STREET 1:		ONE CVS DR.
		CITY:			WOONSOCKET
		STATE:			RI
		ZIP:			02895
		BUSINESS PHONE:		4017651500

	MAIL ADDRESS:	
		STREET 1:		ONE CVS DR.
		CITY:			WOONSOCKET
		STATE:			RI
		ZIP:			02895

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CVS CAREMARK CORP
		DATE OF NAME CHANGE:	20070509

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CVS/CAREMARK CORP
		DATE OF NAME CHANGE:	20070322

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CVS CORP
		DATE OF NAME CHANGE:	19970128
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>ss2014993_s8.htm
<DESCRIPTION>REGISTRATION STATEMENT
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B></B></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 12pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>As filed with the Securities and Exchange Commission
on May 2, 2023</B></P>

<P STYLE="font: 6pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0.5in 0 0; text-align: right"><B>Registration No. 333-</B></P>

<P STYLE="font: 6pt Times New Roman, Times, Serif; margin: 0 0.5in 0 0; text-align: right">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: black 0.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>UNITED STATES </B></P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>FORM S-8</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>REGISTRATION STATEMENT </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>UNDER THE SECURITIES ACT OF 1933</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>CVS HEALTH
CORPORATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Exact name of registrant as specified in its charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 34%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Delaware<BR>
    </B>(State or other jurisdiction of</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">incorporation or organization)</P></TD>
    <TD STYLE="width: 33%; font: 12pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 33%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>05-0494040</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(I.R.S. Employer</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Identification No.)</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>One CVS Drive<BR>
Woonsocket, RI 02895</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Address, including Zip Code, of Principal Executive
Offices)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 14pt"><B>Oak Street Health,
Inc. Omnibus Incentive Plan<BR>
</B></FONT><FONT STYLE="font-size: 10pt">(Full title of the plan)</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Shawn M. Guertin<BR>
Executive Vice President and Chief Financial Officer<BR>
CVS Health Corporation<BR>
One CVS Drive<BR>
Woonsocket, RI 02895</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>(401) 765-1500</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Name, address and telephone number, including area
code, of agent for service)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><I>With a copy to</I></B>:</P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Doreen E. Lilienfeld, Esq.</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Shearman &amp; Sterling LLP </B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>599 Lexington Avenue</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>New York, NY 10022 </B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>(212) 848-7171</B></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Indicate by check mark whether the registrant is a large accelerated filer,
an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of &ldquo;large
accelerated filer,&rdquo; &ldquo;accelerated filer,&rdquo; &ldquo;smaller reporting company,&rdquo; and &ldquo;emerging growth company&rdquo;
in Rule 12b-2 of the Exchange Act.</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Large accelerated filer</P></TD>
    <TD><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#254;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Accelerated filer</FONT></TD>
    <TD><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#168;</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">Non-accelerated filer</FONT></TD>
    <TD><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#168;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Smaller reporting company</FONT></TD>
    <TD><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#168;</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Emerging growth company</FONT></TD>
    <TD><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#168;</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="4"><FONT STYLE="font-size: 10pt">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. <FONT STYLE="font-family: Wingdings">&#168;</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 12pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>EXPLANATORY NOTE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">This Registration Statement on Form S-8 (the &ldquo;Registration
Statement&rdquo;) relates to shares of common stock, par value $0.01 per share (&ldquo;CVS Health Stock&rdquo;), of CVS Health Corporation,
a Delaware corporation (the &ldquo;Company&rdquo;), issuable in respect of certain outstanding and unvested equity awards with respect
to shares of common stock, par value $0.001 per share (&ldquo;Oak Street Stock&rdquo;) of Oak Street Health, Inc., a Delaware
corporation (&ldquo;Oak Street&rdquo;), which were assumed by the Company and converted into equity awards in respect of shares of CVS
Health Stock in connection with the Company&rsquo;s acquisition of Oak Street, as described below. These equity awards were granted pursuant
to the <FONT STYLE="background-color: white">Oak Street Health, Inc. Omnibus Incentive Plan (the &ldquo;Plan&rdquo;). This Registration
Statement also relates to shares of CVS Health Stock reserved and available for issuance pursuant to future awards under the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">On May 2, 2023 (the &ldquo;Effective Time&rdquo;),
pursuant to the Agreement and Plan of Merger (the &ldquo;Merger Agreement&rdquo;), dated as of February 7, 2023, by and among CVS Pharmacy,
Inc., a Rhode Island corporation and wholly-owned subsidiary of the Company (&ldquo;Parent&rdquo;), Oak Street and Halo Merger Sub, Inc.,
a Delaware corporation and wholly-owned subsidiary of Parent (&ldquo;Merger Subsidiary&rdquo;), Merger Subsidiary merged with and into
Oak Street, with Oak Street continuing as a wholly-owned subsidiary of Parent (the &ldquo;Merger&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The Merger Agreement provides that, at the Effective
Time, certain outstanding and unvested restricted stock units with respect to shares of Oak Street Stock granted under <FONT STYLE="background-color: white">the
Plan </FONT>(the &ldquo;Assumed RSUs&rdquo;) converted into restricted stock units with respect to shares of CVS Health Stock. The Merger
Agreement also provides that, at the Effective Time, certain outstanding restricted stock awards with respect to shares of Oak Street
Stock granted under the Plan (the &ldquo;Assumed RSAs&rdquo;) converted into restricted stock awards with respect to shares of CVS Health
Stock. The Assumed RSUs and the Assumed RSAs are generally subject to the same terms and conditions as were applicable to such Assumed
RSUs or Assumed RSAs immediately prior to the Effective Time, except that the number of shares of CVS Health Stock subject to such equity
awards has been adjusted in accordance with the Merger Agreement. Upon the consummation of the Merger, shares of Oak Street Stock that
were reserved and available for issuance <FONT STYLE="background-color: white">pursuant to future awards under the Plan</FONT> were converted
into shares of CVS Health Stock, as adjusted on the same basis as the Assumed RSUs and Assumed RSAs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>PART I<BR>
INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The documents containing the information specified
in Part I of Form S-8 will be sent or given to the participants in the Plan covered by this Registration Statement as required by Rule
428(b)(1) under the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;). Such documents are not required to be filed
with the Securities and Exchange Commission (the &ldquo;Commission&rdquo;) either as part of this Registration Statement or as a prospectus
or prospectus supplement pursuant to Rule 424 under the Securities Act. These documents and the documents incorporated by reference in
this Registration Statement pursuant to Item 3 of Part II of this Registration Statement, taken together, constitute a prospectus that
meets the requirements of Section 10(a) of the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>PART II<BR>
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px">&nbsp;</TD>
    <TD STYLE="width: 96px"><FONT STYLE="font-size: 10pt"><B>Item 3.</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt"><B>Incorporation of Documents by Reference.</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The following documents filed with the Commission by
the Company pursuant to the Securities Act and the Securities Exchange Act of 1934, as amended (the &ldquo;1934 Act&rdquo;), are incorporated
herein by reference:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px"><FONT STYLE="font-size: 10pt">(a)</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">the Company&rsquo;s Annual Report on <A HREF="https://www.sec.gov/Archives/edgar/data/64803/000006480323000009/0000064803-23-000009-index.htm">Form 10-K</A> for the fiscal year ended December 31, 2022, filed with the Commission on February 8, 2023, and any amendment thereto (the &ldquo;2022 Form 10-K&rdquo;); </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px"><FONT STYLE="font-size: 10pt">(b)</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">the Company&rsquo;s Current Reports on Form 8-K filed with the Commission since December 31, 2022 (other than portions of those documents furnished or otherwise not deemed to be filed); and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px"><FONT STYLE="font-size: 10pt">(c)</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">the description of the Company&rsquo;s capital stock contained in the Company&rsquo;s Registration Statement on Form S-4, filed with the Commission on <A HREF="https://www.sec.gov/Archives/edgar/data/64803/000119312518002957/0001193125-18-002957-index.htm">January 4, 2018</A>, including any amendments or supplements thereto, including <A HREF="https://www.sec.gov/Archives/edgar/data/64803/000119312518021755/0001193125-18-021755-index.htm">Amendment No. 1</A> filed on January 26, 2018, <A HREF="https://www.sec.gov/Archives/edgar/data/64803/000119312518031585/0001193125-18-031585-index.htm">Amendment No. 2</A> filed on February 5, 2018 and <A HREF="https://www.sec.gov/Archives/edgar/data/64803/000119312518036987/0001193125-18-036987-index.htm">Amendment No. 3</A> filed on February 9, 2018, as updated by Exhibit 4.21 to the 2022 Form 10-K, together with any amendment or report filed for the purpose of updating such description.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0; text-indent: 0.5in">In addition, all documents subsequently filed by
the Company pursuant to Sections 13(a), 13(c), 14 and 15(d) of the 1934 Act, prior to the filing of a post-effective amendment to this
Registration Statement which indicates that all securities offered have been sold or which deregisters all securities then remaining unsold,
shall be deemed to be incorporated by reference in this Registration Statement and to be a part hereof from the date of the filing of
such documents. Any statement contained herein or in a document all or a portion of which is incorporated or deemed to be incorporated
by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement
contained herein (or in any other subsequently filed document which also is incorporated or deemed to be incorporated by reference herein)
modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded,
to constitute a part of this Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px">&nbsp;</TD>
    <TD STYLE="width: 96px"><FONT STYLE="font-size: 10pt"><B>Item 4.</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt"><B>Description of Securities.</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Not applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px">&nbsp;</TD>
    <TD STYLE="width: 96px"><FONT STYLE="font-size: 10pt"><B>Item 5.</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt"><B>Interests of Named Experts and Counsel.</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Not applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px">&nbsp;</TD>
    <TD STYLE="width: 96px"><FONT STYLE="font-size: 10pt"><B>Item 6.</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt"><B>Indemnification of Directors and Officers</B>.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Section 102(b)(7) of the Delaware General Corporation
Law (the &ldquo;DGCL&rdquo;), permits a corporation to provide in its certificate of incorporation that a director or officer of the corporation
shall not be personally liable to the corporation or its stockholders for monetary damages for breach of fiduciary duty as a director
or officer, provided that such provisions shall not eliminate or limit the liability of (i) a director or officer for any breach of the
director&rsquo;s or officer&rsquo;s duty of loyalty to the corporation or its stockholders, (ii) a director or officer for acts or omissions
not in good faith or which involve intentional misconduct or a knowing violation of law, (iii) a director under Section 174 of the DGCL,
(iv) for any transaction from which the director or officer derived an improper personal benefit, or (v) an officer in any action by or
in the right of the corporation. No such provision shall eliminate or limit the liability of a director or officer for any act or omission
occurring before the date when such provision becomes effective. The Company&rsquo;s Restated Certificate of Incorporation (the &ldquo;Company
Charter&rdquo;) limits the personal liability of a director to the Company and its stockholders for monetary damages for a breach of fiduciary
duty as a director to the fullest extent permitted by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Section 145 of the DGCL provides that a corporation
may indemnify directors and officers as well as other employees and individuals against expenses (including attorneys&rsquo; fees), judgments,
fines and amounts paid in settlement actually and reasonably incurred by such person in connection with any threatened, pending or completed
actions, suits or proceedings in which such person is made a party by reason of such person being or having been a director, officer,
employee or agent of the Company. The DGCL provides that Section 145 is not exclusive of other rights to which those seeking indemnification
may be entitled under any bylaw, agreement, vote of stockholders or disinterested directors or otherwise. Expenses, including attorneys&rsquo;
fees, incurred by any such person in defending any such action, suit or proceeding shall be paid or reimbursed by the Company in advance
of the final disposition of such action, suit or proceeding upon receipt by the Company of an undertaking of such person to repay such
expenses if it shall ultimately be determined that such person is not entitled to be indemnified by the Company. The Company Charter provides
for indemnification of directors and officers of the Company against liability they may incur in their capacities as such to the fullest
extent permitted under the DGCL.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The directors and officers of the Company are insured
under a policy of directors&rsquo; and officers&rsquo; liability insurance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px">&nbsp;</TD>
    <TD STYLE="width: 96px; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Item 7.</B></FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Exemption from Registration Claimed.</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Not applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px">&nbsp;</TD>
    <TD STYLE="width: 96px; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Item 8.</B></FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Exhibits.</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><U>Exhibit No.</U> &#9;<U>Exhibit Description</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px">&nbsp;</TD>
    <TD STYLE="width: 96px; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">4.1</FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/64803/000119312518184593/d456958dex31c.htm">Restated Certificate of Incorporation of the Company dated June 4, 2018 (incorporated by reference to Exhibit 3.1C to the Company&rsquo;s Current Report on Form 8-K filed on June 5, 2018).</A></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px">&nbsp;</TD>
    <TD STYLE="width: 96px; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">4.2</FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/64803/000094787122001199/ss1535680_ex0301.htm">By-Laws of the Company, as amended and restated November 17, 2022 (incorporated by reference to Exhibit 3.1 to the Company&rsquo;s Current Report on Form 8-K filed on November 21, 2022).</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 12pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">5.1*</FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><A HREF="ss2014993_ex0501.htm">Opinion of Shearman &amp; Sterling LLP.</A></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px">&nbsp;</TD>
    <TD STYLE="width: 96px; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">23.1*</FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><A HREF="ss2014993_ex2301.htm">Consent of Ernst &amp; Young LLP.</A></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px">&nbsp;</TD>
    <TD STYLE="width: 96px; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">23.2*</FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><A HREF="ss2014993_ex0501.htm">Consent of Shearman &amp; Sterling LLP (contained in the Opinion Filed as Exhibit 5.1).</A></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px">&nbsp;</TD>
    <TD STYLE="width: 96px"><FONT STYLE="font-size: 10pt">24.1*</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt"><A HREF="#a_001">Power of Attorney (included on the signature pages).</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">99.1*</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt"><A HREF="ss2014993_ex9901.htm">Oak Street Health, Inc. Omnibus Incentive Plan.</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">107.1*</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt"><A HREF="ss2014993_ex1071.htm">Filing Fee Table.</A></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px">&nbsp;</TD>
    <TD STYLE="width: 96px; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">____________</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">*Filed herewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px">&nbsp;</TD>
    <TD STYLE="width: 96px; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Item 9.</B></FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Undertakings</B>.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">(a) The undersigned registrant hereby undertakes:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">To file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 96px">&nbsp;</TD>
    <TD STYLE="width: 48px; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">(i)</FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">To include any prospectus required by Section 10(a)(3) of the Securities Act;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 96px">&nbsp;</TD>
    <TD STYLE="width: 48px; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">(ii)</FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">To reflect in the prospectus any facts or events arising after the effective date of the Registration Statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the Registration Statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20% change in the maximum aggregate offering price set forth in the &ldquo;Calculation of Registration Fee&rdquo; table in the effective Registration Statement; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 96px">&nbsp;</TD>
    <TD STYLE="width: 48px; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">(iii)</FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">To include any material information with respect to the plan of distribution not previously disclosed in the Registration Statement or any material change to such information in the Registration Statement;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><I>provided</I>, <I>however</I>, that paragraphs (a)(1)(i) and
(a)(1)(ii) do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports
filed with or furnished to the Commission by the registrant pursuant to Section 13 or Section 15(d) of the 1934 Act that are incorporated
by reference in the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px">&nbsp;</TD>
    <TD STYLE="width: 48px; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">The undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the registrant&rsquo;s annual report pursuant to Section 13(a) or Section 15(d) of the 1934 Act (and, where applicable, each filing of an employee benefit plan&rsquo;s annual report pursuant to Section 15(d) of the 1934 Act) that is incorporated by reference in the Registration Statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px">&nbsp;</TD>
    <TD STYLE="width: 48px; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">(c)</FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0">&nbsp;<BR STYLE="clear: both"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Pursuant to the requirements of the Securities Act
of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing
on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized,
in the City of Woonsocket, State of Rhode Island, on the 2nd day of May, 2023.</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 5%; font: 12pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 35%; font: 12pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 12pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">CVS Health Corporation</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 12pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="padding-left: 12pt; font: 12pt Times New Roman, Times, Serif; text-indent: -12pt">&nbsp;</TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 12pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="padding-left: 12pt; font: 12pt Times New Roman, Times, Serif; text-indent: -12pt"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">/s/ Shawn M. Guertin</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 12pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="padding-left: 12pt; font: 12pt Times New Roman, Times, Serif; text-indent: -12pt"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;Shawn M. Guertin</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 12pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Executive Vice President and Chief</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Financial Officer</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><A NAME="a_001" TITLE="powerofattorney"></A>POWER OF ATTORNEY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">KNOW ALL PERSONS BY THESE PRESENTS, that each person
whose signature appears below constitutes and appoints each of Shawn M. Guertin and Colleen M. McIntosh as his or her true and lawful
attorney-in-fact and agent, upon the action of either such appointee, with full power of substitution and resubstitution, to do any and
all acts and things and execute, in the name of the undersigned, any and all instruments which each of said attorneys-in-fact and agents
may deem necessary or advisable in order to enable CVS Health Corporation to comply with the Securities Act of 1933, as amended (the &ldquo;Securities
Act&rdquo;), and any requirements of the Securities and Exchange Commission (the &ldquo;Commission&rdquo;) in respect thereof, in connection
with the filing with the Commission of this Registration Statement under the Securities Act, including specifically, but without limitation,
power and authority to sign the name of the undersigned to such Registration Statement, and any amendments to such Registration Statement
(including post-effective amendments), and to file or cause to be filed the same with all exhibits thereto and other documents in connection
therewith with the Commission, to sign any and all applications, registration statements, notices or other documents necessary or advisable
to comply with applicable state securities laws, and to file or cause to be filed the same, together with other documents in connection
therewith with the appropriate state securities authorities, granting unto each of said attorneys-in-fact and agents full power and authority
to do and to perform each and every act and thing requisite or necessary to be done in and about the premises, as fully and to all intents
and purposes as the undersigned might or could do in person, hereby ratifying and confirming all that each of said attorneys-in-fact and
agents may lawfully do or cause to be done by virtue of this Power of Attorney.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Pursuant to the requirements of the Securities Act
of 1933, as amended, this Registration Statement has been signed on the 2nd day of May, 2023 by the following persons in the following
capacities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD STYLE="vertical-align: top; width: 35%; padding-bottom: 6pt"><FONT STYLE="font-size: 10pt"><U>Signature</U></FONT></TD>
    <TD STYLE="vertical-align: top; width: 65%; padding-left: 9pt"><FONT STYLE="font-size: 10pt"><U>Title</U></FONT></TD>
    </TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1pt solid; padding-top: 6pt"><FONT STYLE="font-size: 10pt">/s/ Fernando Aguirre</FONT></TD>
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-size: 10pt">Director</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Fernando Aguirre</FONT></TD>
    <TD STYLE="padding-left: 9pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 9pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Jeffrey R. Balser, M.D., Ph.D.</FONT></TD>
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-size: 10pt">Director</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Jeffrey R. Balser, M.D., Ph.D.</FONT></TD>
    <TD STYLE="padding-left: 9pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 9pt">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ C. David Brown II</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-left: 9pt"><FONT STYLE="font-size: 10pt">Director</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">C. David Brown II</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-left: 9pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 9pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ James D. Clark</FONT></TD>
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-size: 10pt">Senior Vice President &ndash; Controller and Chief Accounting Officer (Principal Accounting Officer)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">James D. Clark</FONT></TD>
    <TD STYLE="padding-left: 9pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 9pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Alecia A. DeCoudreaux</FONT></TD>
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-size: 10pt">Director</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Alecia A. DeCoudreaux</FONT></TD>
    <TD STYLE="padding-left: 9pt">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 35%">&nbsp;</TD>
    <TD STYLE="padding-left: 9pt; width: 65%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Nancy-Ann M. DeParle</FONT></TD>
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-size: 10pt">Director</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Nancy-Ann M. DeParle</FONT></TD>
    <TD STYLE="padding-left: 9pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 9pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Roger N. Farah</FONT></TD>
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-size: 10pt">Chair of the Board and Director</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Roger N. Farah</FONT></TD>
    <TD STYLE="padding-left: 9pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 9pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Anne M. Finucane</FONT></TD>
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-size: 10pt">Director</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Anne M. Finucane</FONT></TD>
    <TD STYLE="padding-left: 9pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 9pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Shawn M. Guertin</FONT></TD>
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-size: 10pt">Executive Vice President and Chief Financial Officer (Principal Financial Officer)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Shawn M. Guertin</FONT></TD>
    <TD STYLE="padding-left: 9pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 9pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Edward J. Ludwig</FONT></TD>
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-size: 10pt">Director</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Edward J. Ludwig</FONT></TD>
    <TD STYLE="padding-left: 9pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 9pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Karen S. Lynch</FONT></TD>
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-size: 10pt">President and Chief Executive Officer (Principal Executive Officer) and Director</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Karen S. Lynch</FONT></TD>
    <TD STYLE="padding-left: 9pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 9pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Jean-Pierre Millon</FONT></TD>
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-size: 10pt">Director</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Jean-Pierre Millon</FONT></TD>
    <TD STYLE="padding-left: 9pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 9pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Mary L. Schapiro</FONT></TD>
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-size: 10pt">Director</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Mary L. Schapiro</FONT></TD>
    <TD STYLE="padding-left: 9pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 9pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ William C. Weldon</FONT></TD>
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-size: 10pt">Director</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">William C. Weldon</FONT></TD>
    <TD STYLE="padding-left: 9pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 9pt">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>ss2014993_ex0501.htm
<DESCRIPTION>OPINION
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>EXHIBIT 5.1 </B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><IMG SRC="image_01.jpg" ALT="LOGO" STYLE="height: 12px; width: 247px"></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: center">599 Lexington Avenue</P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center">New York, NY 10022-6069</P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center">+1.212.848.4000</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.25in 0 0; text-align: right">May 2, 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">CVS Health Corp.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">One CVS Drive</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Woonsocket, RI 02895</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-indent: 24.5pt">We are acting as counsel for CVS Health Corp.,
a Delaware corporation (the &#8220;<U>Company</U>&#8221;), in connection with preparation and filing by the Company of a registration
statement on Form S-8 (the &#8220;<U>Registration Statement</U>&#8221;) with the Securities and Exchange Commission under the Securities
Act of 1933, as amended (the &#8220;<U>Securities Act</U>&#8221;), with respect to 11,195,630 shares of common stock, par value
$0.01, of the Company (the &#8220;<U>Shares</U>&#8221;) that may be delivered from time to time pursuant to the Oak Street Health, Inc.
Omnibus Incentive Plan (the &#8220;<U>Plan</U>&#8221;). In connection with the foregoing, we have reviewed originals or copies identified
to our satisfaction of the following documents:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-indent: 24.5pt">(a) The Registration Statement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-indent: 24.5pt">(b) The certificate of incorporation and bylaws
of the Company, in each case as amended to date; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-indent: 24.5pt">(c) Originals or copies of such other corporate
records of the Company, certificates of public officials and of officers of the Company, and agreements and other documents as we have
deemed necessary as a basis for the opinions expressed below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-indent: 24.5pt">In our examination, we have assumed the genuineness
of all signatures, the authenticity of all documents, certificates and instruments submitted to us as originals and the conformity with
originals of all documents submitted to us as copies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-indent: 24.5pt">Our opinion set forth below is based on the
text of the Plan as referenced in the Exhibit Index to the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-indent: 24.5pt">Our opinion expressed below is limited to the
General Corporation Law of the State of Delaware, and we do not express any opinion herein concerning any other law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-indent: 24.5pt">Based upon and subject to the foregoing and
having regard for such legal considerations as we have deemed relevant, we are of the opinion that authorized but not previously issued
Shares that may be delivered under the Plan have been duly authorized by the Company and, when (a) issued and delivered by the Company
in accordance with the terms of the Plan and (b) paid for in full in accordance with the terms of the Plan, will be validly issued, fully
paid and non-assessable.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-indent: 24.5pt">This opinion letter speaks only as of the date
hereof. We expressly disclaim any responsibility to advise you of any development or circumstance of any kind, including any change of
law or fact that may occur after the date of this opinion letter that might affect the opinions expressed herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-indent: 24.5pt">We hereby consent to the filing of this opinion
as an exhibit to the Registration Statement. In giving this consent, we do not thereby concede that we come within the category of persons
whose consent is required by the Securities Act or the General Rules and Regulations of the Securities and Exchange Commission promulgated
thereunder.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 10pt; font: 12pt Times New Roman, Times, Serif; text-indent: -10pt"><FONT STYLE="font-size: 10pt">Very truly yours,</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 35%">&nbsp;</TD>
    <TD STYLE="width: 65%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-size: 10pt">/s/ Shearman &amp; Sterling LLP</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-top: black 1pt solid; font: 12pt Times New Roman, Times, Serif; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-size: 10pt">Shearman &amp; Sterling LLP</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>ss2014993_ex2301.htm
<DESCRIPTION>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt">&nbsp;</P>

<P STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; background-color: white"><B>EXHIBIT 23.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 24pt 0 0; text-align: center; background-color: white"><B>Consent of Independent
Registered Public Accounting Firm</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: justify; background-color: white">We consent to the
incorporation by reference in the Registration Statement (Form S-8) pertaining to the Oak Street Health, Inc. Omnibus Incentive Plan of
our reports dated February 8, 2023, with respect to the consolidated financial statements of CVS Health Corporation and the effectiveness
of internal control over financial reporting of CVS Health Corporation included in its Annual Report (Form 10-K) for the year ended December
31, 2022, filed with the Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 35%; border-bottom: Black 1pt solid; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">/s/ Ernst &amp; Young LLP</FONT></TD>
    <TD STYLE="width: 65%">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">Boston, Massachusetts</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">May 2, 2023</P>

<P STYLE="font: 6pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<P STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt">&nbsp;</P>

<P STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt">&nbsp;</P>

<P STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt">&nbsp;</P>

<P STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt">&nbsp;</P>

<P STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt">&nbsp;</P>

<P STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt">&nbsp;</P>

<P STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt">&nbsp;</P>

<P STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt">&nbsp;</P>

<P STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt">&nbsp;</P>

<P STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt">&nbsp;</P>

<P STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt">&nbsp;</P>

<P STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt">&nbsp;</P>

<P STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt">&nbsp;</P>

<P STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt">&nbsp;</P>

<P STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>4
<FILENAME>ss2014993_ex9901.htm
<DESCRIPTION>OAK STREET HEALTH, INC. OMNIBUS INCENTIVE PLAN.
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: right"><FONT STYLE="font-size: 10pt">EXHIBIT 99.1</FONT></P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">OAK STREET HEALTH, INC.</P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: center">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 3pt auto; width: 40%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">OMNIBUS INCENTIVE PLAN</P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: center">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 3pt auto; width: 40%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: uppercase"><B>Article
I</B></FONT><BR>
<B>PURPOSE; EFFECTIVE DATE; TERM</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>1.1</B></TD><TD STYLE="text-align: justify"><B><U>Purpose</U></B>. The purpose of this Oak Street Health, Inc. Omnibus Incentive Plan is to enhance
the profitability and value of the Company for the benefit of its Stockholders by enabling the Company to offer Eligible Individuals stock-
and cash&#45;based incentives in order to attract, retain, and reward such individuals and strengthen the mutuality of interests between
such individuals and the Stockholders.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>1.2</B></TD><TD STYLE="text-align: justify"><B><U>Effective Date</U></B>. The Plan became effective on August 5, 2020 (the <B>&ldquo;<U>Effective
Date</U>&rdquo;</B>).</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>1.3</B></TD><TD STYLE="text-align: justify"><B><U>Term</U></B>. No Award may be granted on or after the 10th anniversary of the Effective Date, but
Awards granted before such 10th anniversary may extend beyond that date.</TD></TR></TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: uppercase"><B>Article
II</B></FONT><BR>
<B>DEFINITIONS</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: -0.5in">For purposes of
the Plan, the following terms will have the following meanings:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>2.1</B></TD><TD STYLE="text-align: justify"><B>&ldquo;<U>Affiliate</U>&rdquo;</B> means each of the following: (a)&nbsp;any Subsidiary; (b)&nbsp;any
Parent; (c)&nbsp;any corporation, trade, or business that is directly or indirectly controlled 50% or more (whether by ownership of stock,
assets, or an equivalent ownership interest or voting interest) by the Company or any Affiliate; (d)&nbsp;any trade or business that directly
or indirectly controls 50% or more (whether by ownership of stock, assets, or an equivalent ownership interest or voting interest) of
the Company; and (e)&nbsp;any other entity in which the Company or any Affiliate has a material equity interest and that is designated
as an &ldquo;Affiliate&rdquo; by resolution of the Committee.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>2.2</B></TD><TD STYLE="text-align: justify"><B>&ldquo;<U>Applicable Law</U>&rdquo; </B>means the requirements related to or implicated by the administration
of the Plan under applicable state corporate laws, United States federal and state securities laws, the Code, any stock exchange or quotation
system on which the Shares are listed or quoted, and the applicable laws of any foreign country or jurisdiction where Awards are granted.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>2.3</B></TD><TD STYLE="text-align: justify"><B>&ldquo;<U>Award</U>&rdquo;</B> means any award granted under the Plan of any Stock Option, Stock Appreciation
Right, Restricted Shares, Performance Award, Other Share-Based Award, or Other Cash-Based Award. All Awards will be granted by, confirmed
by, and subject to the terms and conditions of, a written Award Agreement executed by the Company and the Participant.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>2.4</B></TD><TD STYLE="text-align: justify"><B>&ldquo;<U>Award Agreement</U>&rdquo;</B> means the written or electronic agreement setting forth the
terms and conditions applicable to an Award.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>2.5</B></TD><TD STYLE="text-align: justify"><B>&ldquo;<U>Board</U>&rdquo;</B> means the Board of Directors of the Company.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>2.6</B></TD><TD STYLE="text-align: justify"><B>&ldquo;<U>Business Combination</U>&rdquo;</B> has the meaning set forth in <U>Section&nbsp;11.2(c)</U>.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>2.7</B></TD><TD STYLE="text-align: justify"><B>&ldquo;<U>Cause</U>&rdquo;</B> means, unless otherwise determined by the Committee in the applicable
Award Agreement, with respect to an Eligible Employee&rsquo;s or Consultant&rsquo;s Separation from Service, the following: (a) in the
case where there is no employment agreement, consulting agreement, change in control agreement, or similar agreement in effect between
the Company or an Affiliate and the Participant at the time of the grant of the Award (or where there is such an agreement but it does
not define &ldquo;cause&rdquo; (or words of like import)), Separation from Service due to a Participant&rsquo;s insubordination, dishonesty,
fraud, incompetence, moral turpitude, willful misconduct, refusal to perform the Participant&rsquo;s duties or responsibilities (for any
reason other than illness or incapacity), repeated or material violation of any employment policy, violation or breach of any confidentiality
agreement, work product agreement, or other agreement between the Participant and the Company, or materially unsatisfactory performance
of the Participant&rsquo;s duties to the Company or an Affiliate; or (b) in the case where there is an employment agreement, consulting
agreement, change in control agreement, or similar agreement in effect between the Company or an Affiliate and the Participant at the
time of the grant of the Award that defines &ldquo;cause&rdquo; (or words of like import), &ldquo;cause&rdquo; as defined under such agreement.
Notwithstanding any foregoing term or condition of this definition of Cause, with respect to a Non-Employee Director&rsquo;s Separation
from Service, <B>&ldquo;<U>Cause</U>&rdquo;</B> means an act or failure to act that constitutes cause for removal of a director under
applicable Delaware law.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>2.8</B></TD><TD STYLE="text-align: justify"><B>&ldquo;<U>Change in Control</U>&rdquo;</B> has the meaning set forth in <U>Section&nbsp;11.2</U>.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>2.9</B></TD><TD STYLE="text-align: justify"><B>&ldquo;<U>Change in Control Price</U>&rdquo;</B> has the meaning set forth in <U>Section&nbsp;11.1</U>.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>2.10</B></TD><TD STYLE="text-align: justify"><B>&ldquo;<U>Code</U>&rdquo; </B>means the Internal Revenue Code of 1986.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>2.11</B></TD><TD STYLE="text-align: justify"><B>&ldquo;<U>Committee</U>&rdquo;</B> means any committee of the Board duly authorized by the Board to
administer the Plan. If no committee is duly authorized by the Board to administer the Plan, &ldquo;Committee&rdquo; will be deemed to
refer to the Board for all purposes under the Plan.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>2.12</B></TD><TD STYLE="text-align: justify"><B>&ldquo;<U>Common Stock</U>&rdquo;</B> means the shares of common stock, $0.001 par value per share,
of the Company. Unless otherwise determined by the Committee, the Common Stock subject to any Award must constitute &ldquo;service recipient
stock&rdquo; under Section&nbsp;409A (or otherwise not subject the Award to Section&nbsp;409A).</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>2.13</B></TD><TD STYLE="text-align: justify"><B>&ldquo;<U>Company</U>&rdquo; </B>means Oak Street Health, Inc., a Delaware corporation, and its successors
by operation of law.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>2.14</B></TD><TD STYLE="text-align: justify"><B>&ldquo;<U>Consultant</U>&rdquo;</B> means an advisor or consultant to the Company or an Affiliate.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>2.15</B></TD><TD STYLE="text-align: justify"><B>&ldquo;<U>Detrimental Conduct</U>&rdquo; </B>means, as determined by the Company, the Participant&rsquo;s
serious misconduct or unethical behavior, including any of the following: (a)&nbsp;any violation by the Participant of a restrictive covenant
agreement that the Participant has entered into with the Company or an Affiliate (covering, for example, confidentiality, non-competition,
non-solicitation, non-disparagement, etc.); (b)&nbsp;any conduct by the Participant that could result in the Participant&rsquo;s Separation
from Service for Cause; (c)&nbsp;the commission of a criminal act by the Participant, whether or not performed in the workplace, that
subjects, or if generally known would subject, the Company or an Affiliate to public ridicule or embarrassment, or other improper or intentional
conduct by the Participant causing reputational harm to the Company, an Affiliate, or a client or former client of the Company or an Affiliate;
(d)&nbsp;the Participant&rsquo;s breach of a fiduciary duty owed to the Company or an Affiliate or a client or former client of the Company
or an Affiliate; (e)&nbsp;the Participant&rsquo;s intentional violation, or grossly negligent disregard, of the Company&rsquo;s or an
Affiliate&rsquo;s policies, rules, or procedures; or (f)&nbsp;the Participant taking or maintaining trading positions that result in a
need to restate financial results in a subsequent reporting period or that result in a significant financial loss to the Company or an
Affiliate.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>2.16</B></TD><TD STYLE="text-align: justify"><B>&ldquo;<U>Disability</U>&rdquo;</B> means, unless otherwise determined by the Committee in the applicable
Award Agreement, with respect to a Participant&rsquo;s Separation from Service, a permanent and total disability as defined in Code Section&nbsp;22(e)(3).
A Disability will only be deemed to occur at the time of the determination by the Committee of the Disability; <U>provided</U>, <U>however</U>,
that, for Awards that are subject to Section&nbsp;409A, Disability means that a Participant is disabled under Section&nbsp;409A.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>2.17</B></TD><TD STYLE="text-align: justify"><B>&ldquo;<U>Effective Date</U>&rdquo;</B> has the meaning set forth in <U>Section&nbsp;1.2</U>.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>2.18</B></TD><TD STYLE="text-align: justify"><B>&ldquo;<U>Eligible Employee</U>&rdquo;</B> means each employee of the Company or an Affiliate.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>2.19</B></TD><TD STYLE="text-align: justify"><B>&ldquo;<U>Eligible Individual</U>&rdquo;</B> means each Eligible Employee, Non-Employee Director, and
Consultant who is designated by the Committee as eligible to receive an Award.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>2.20</B></TD><TD STYLE="text-align: justify"><B>&ldquo;<U>Exchange Act</U>&rdquo;</B> means the Securities Exchange Act of 1934.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>2.21</B></TD><TD STYLE="text-align: justify"><B>&ldquo;<U>Fair Market Value</U>&rdquo;</B> means, as of any date and except as provided below, the
last sales price reported for the Common Stock on the applicable date as reported on the principal stock exchange in the United States
on which the Common Stock is then listed, or if the Common Stock is not listed, or otherwise reported or quoted, the Committee will determine
the Fair Market Value taking into account the requirements of Section&nbsp;409A. For purposes of the grant of any Award, the applicable
date will be the trading day immediately before the date on which the Award is granted. For purposes of any Award granted in connection
with the Registration Date, the Fair Market Value will be the public offering price in the initial public offering as set forth on the
cover of the final prospectus. For purposes of the purchase of any Award, the applicable date will be the date a notice of purchase is
received by the Company or, if not a day on which the applicable market is open, the next day that it is open.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>2.22</B></TD><TD STYLE="text-align: justify"><B>&ldquo;<U>Family Member</U>&rdquo;</B> means the Participant&rsquo;s child, stepchild, grandchild,
parent, stepparent, grandparent, spouse, former spouse, sibling, niece, nephew, mother-in-law, father-in-law, son-in-law, daughter-in-law,
brother-in-law, or sister-in-law, including adoptive relationships, any person sharing the Participant&rsquo;s household (other than a
tenant or employee), a trust in which these persons have more than 50% of the beneficial interest, a foundation in which these persons
(or the Participant) control the management of assets, and any other entity in which these persons (or the Participant) own more than
50% of the voting interests.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>2.23</B></TD><TD STYLE="text-align: justify"><B>&ldquo;<U>GAAP</U>&rdquo;</B> means generally accepted accounting principles.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>2.24</B></TD><TD STYLE="text-align: justify"><B>&ldquo;<U>Incentive Stock Option</U>&rdquo;</B> or <B>&ldquo;<U>ISO</U>&rdquo; </B>means any Stock
Option awarded to an Eligible Employee of the Company, its Subsidiaries, or any Parent intended to be and designated as an &ldquo;incentive
stock option&rdquo; within the meaning of Code Section&nbsp;422.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>2.25</B></TD><TD STYLE="text-align: justify"><B>&ldquo;<U>Incumbent Directors</U>&rdquo;</B> has the meaning set forth in <U>Section&nbsp;11.2(b)</U>.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>2.26</B></TD><TD STYLE="text-align: justify"><B>&ldquo;<U>Lead Underwriter</U>&rdquo; </B>has the meaning set forth in <U>Section&nbsp;13.21</U>.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>2.27</B></TD><TD STYLE="text-align: justify"><B>&ldquo;<U>Lock-Up Period</U>&rdquo;</B> has the meaning set forth in <U>Section&nbsp;13.21</U>.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>2.28</B></TD><TD STYLE="text-align: justify"><B>&ldquo;<U>Non-Employee Director</U>&rdquo;</B> means a member of the Board or the board of directors
of an Affiliate who is not an active employee of the Company or an Affiliate.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>2.29</B></TD><TD STYLE="text-align: justify"><B>&ldquo;<U>Nonstatutory Stock Option</U>&rdquo;</B> means any Stock Option that is not an ISO.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>2.30</B></TD><TD STYLE="text-align: justify"><B>&ldquo;<U>Other Cash-Based Award</U>&rdquo;</B> means an award granted to an Eligible Individual under
<U>Section&nbsp;10.3</U> that is payable in cash at the time or times and subject to the terms and conditions determined by the Committee.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>2.31</B></TD><TD STYLE="text-align: justify"><B>&ldquo;<U>Other Share-Based Award</U>&rdquo;</B> means an award granted to an Eligible Individual under
<U>Article X</U> that is valued in whole or in part by reference to, or is payable in or otherwise based on, Common Stock, including an
award valued by reference to an Affiliate.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>2.32</B></TD><TD STYLE="text-align: justify"><B>&ldquo;<U>Parent</U>&rdquo;</B> means any parent corporation of the Company within the meaning of Code
Section&nbsp;424(e).</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>2.33</B></TD><TD STYLE="text-align: justify"><B>&ldquo;<U>Participant</U>&rdquo; </B>means an Eligible Individual who has been granted, and holds,
an Award.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>2.34</B></TD><TD STYLE="text-align: justify"><B>&ldquo;<U>Performance Award</U>&rdquo;</B> means an an award granted to an Eligible Individual under
<U>Article IX</U> contingent upon achieving specified Performance Goals.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>2.35</B></TD><TD STYLE="text-align: justify"><B>&ldquo;<U>Performance Goals</U>&rdquo;</B> means goals established by the Committee as contingencies
for Awards to vest or become exercisable or distributable, which may be based on business objectives or other measures of performance
as the Committee, in its discretion, deems appropriate. Performance Goals may differ among Awards granted to any one Participant or to
different Participants. The Committee may also designate additional business objectives on which the Performance Goals may be based; and
adjust, modify, or amend the aforementioned business objectives.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>2.36</B></TD><TD STYLE="text-align: justify"><B>&ldquo;<U>Performance Period</U>&rdquo;</B> means the designated period during which Performance Goals
must be satisfied with respect to a Performance Award.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>2.37</B></TD><TD STYLE="text-align: justify"><B>&ldquo;<U>Person</U>&rdquo;</B> means an individual, a partnership, a corporation, a limited liability
company, an association, a joint stock company, a trust, a joint venture, an unincorporated organization, and a government or any branch,
department, agency, political subdivision, or official thereof.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>2.38</B></TD><TD STYLE="text-align: justify"><B>&ldquo;<U>Plan</U>&rdquo;</B> means this Oak Street Health, Inc. Omnibus Incentive Plan.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>2.39</B></TD><TD STYLE="text-align: justify"><B>&ldquo;<U>Proceeding</U>&rdquo; </B>has the meaning set forth in <U>Section&nbsp;13.10</U>.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>2.40</B></TD><TD STYLE="text-align: justify"><B>&ldquo;<U>Registration Date</U>&rdquo;</B> means the date on which the Company consummates the sale
of its Common Stock in a bona fide, firm commitment underwriting pursuant to a registration statement under the Securities Act.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>2.41</B></TD><TD STYLE="text-align: justify"><B>&ldquo;<U>Restricted Shares</U>&rdquo;</B> means restricted Shares granted to an Eligible Individual
under <U>Article VIII</U>.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>2.42</B></TD><TD STYLE="text-align: justify"><B>&ldquo;<U>Restriction Period</U>&rdquo;</B> has the meaning set forth in <U>Section&nbsp;8.3(a)</U>.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>2.43</B></TD><TD STYLE="text-align: justify"><B>&ldquo;<U>Rule 16b-3</U>&rdquo;</B> means Rule 16b&#45;3 under Section&nbsp;16(b) of the Exchange Act.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>2.44</B></TD><TD STYLE="text-align: justify"><B>&ldquo;<U>Section&nbsp;409A</U>&rdquo;</B> means Code Section&nbsp;409A.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>2.45</B></TD><TD STYLE="text-align: justify"><B>&ldquo;<U>Securities Act</U>&rdquo;</B> means the Securities Act of 1933.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>2.46</B></TD><TD STYLE="text-align: justify"><B>&ldquo;<U>Separation from Service</U>&rdquo;</B> means, unless otherwise determined by the Committee
or the Company, the termination of the applicable Participant&rsquo;s employment with, and performance of services for, the Company and
all Affiliates, including by reason of the fact that the Participant&rsquo;s employer or other service recipient ceases to be an Affiliate
of the Company. Unless otherwise determined by the Company, if a Participant&rsquo;s employment or service with the Company or an Affiliate
terminates but the Participant continues to provide services to the Company or an Affiliate in a Non-Employee Director capacity or as
an Eligible Employee or Consultant, as applicable, such change in status will not be considered a Separation from Service. Approved temporary
absences from employment because of illness, vacation, or leave of absence and transfers among the Company and its Affiliates will not
be considered Separations from Service. Notwithstanding the foregoing definition of Separation from Service, with respect to any Award
that constitutes nonqualified deferred compensation under Section&nbsp;409A, &ldquo;Separation from Service&rdquo; means a &ldquo;separation
from service&rdquo; as defined under Section&nbsp;409A.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>2.47</B></TD><TD STYLE="text-align: justify"><B>&ldquo;<U>Share</U>&rdquo;</B> means a share of Common Stock.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>2.48</B></TD><TD STYLE="text-align: justify"><B>&ldquo;<U>Share Reserve</U>&rdquo;</B> has the meaning set forth in <U>Section&nbsp;4.1</U>.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>2.49</B></TD><TD STYLE="text-align: justify"><B>&ldquo;<U>Stock Appreciation Right</U>&rdquo;</B> means a right granted to an Eligible Individual under
<U>Article VII</U> to receive an amount in cash or Shares equal to the difference between (a)&nbsp;the Fair Market Value of a Share on
the date such right is exercised and (b)&nbsp;the per Share exercise price of such right.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>2.50</B></TD><TD STYLE="text-align: justify"><B>&ldquo;<U>Stock Option</U>&rdquo;</B> means an option to purchase Shares granted to an Eligible Individual
under <U>Article VI</U>.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>2.51</B></TD><TD STYLE="text-align: justify"><B>&ldquo;<U>Stockholder</U>&rdquo;</B> means a stockholder of the Company.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>2.52</B></TD><TD STYLE="text-align: justify"><B>&ldquo;<U>Subsidiary</U>&rdquo;</B> means any subsidiary corporation of the Company within the meaning
of Code Section&nbsp;424(f).</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>2.53</B></TD><TD STYLE="text-align: justify"><B>&ldquo;<U>Ten Percent Stockholder</U>&rdquo; </B>means a Person owning stock possessing more than 10%
of the total combined voting power of all classes of stock of the Company, its Subsidiaries, or any Parent.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>2.54</B></TD><TD STYLE="text-align: justify"><B>&ldquo;<U>Transfer</U>&rdquo;</B> means (a) when used as a noun, any direct or indirect transfer, sale,
assignment, pledge, hypothecation, encumbrance, or other disposition, whether for value or no value and whether voluntary or involuntary,
and (b) when used as a verb, to directly or indirectly transfer, sell, assign, pledge, encumber, charge, hypothecate, or otherwise dispose
of, whether for value or for no value and whether voluntarily or involuntarily. &ldquo;Transferred&rdquo; and &ldquo;Transferable&rdquo;
have a correlative meaning under the Plan.</TD></TR></TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: uppercase"><B>Article
III</B></FONT><BR>
<B>ADMINISTRATION</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>3.1</B></TD><TD STYLE="text-align: justify"><B><U>Committee</U></B>. The Plan will be administered and interpreted by the Committee. To the extent
required by Applicable Law, it is intended that each member of the Committee will qualify as (a) a &ldquo;non-employee director&rdquo;
under Rule 16b-3 and (b) an &ldquo;independent director&rdquo; under the rules of the principal stock exchange in the United States on
which the Common Stock is then listed, as applicable. If it is later determined that 1 or more members of the Committee do not so qualify,
actions taken by the Committee before such determination will be valid despite such failure to qualify.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>3.2</B></TD><TD STYLE="text-align: justify"><B><U>Grants of Awards</U></B>. The Committee will have full authority to grant, under the terms and conditions
of the Plan, to Eligible Individuals: (i)&nbsp;Stock Options, (ii)&nbsp;Stock Appreciation Rights, (iii)&nbsp;Restricted Shares, (iv)&nbsp;Performance
Awards, (v)&nbsp;Other Share-Based Awards, and (vi)&nbsp;Other Cash-Based Awards. In particular, the Committee will have the authority:</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">to select the Eligible Individuals to whom Awards may be granted;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">to determine whether and to what extent Awards, or any combination thereof, are to be granted to 1 or
more Eligible Individuals;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">to determine the number of Shares to be covered by each Award;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">to determine the terms and conditions, not inconsistent with the terms and conditions of the Plan, of
all Awards;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD STYLE="text-align: justify">to determine the amount of cash to be covered by each Award;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(f)</TD><TD STYLE="text-align: justify">to determine whether, to what extent, and under what circumstances grants of Stock Options and other Awards
are to operate on a tandem basis or in conjunction with or apart from other awards made by the Company outside of the Plan;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(g)</TD><TD STYLE="text-align: justify">to determine whether and under what circumstances a Stock Option may be settled in cash, Common Stock,
or Restricted Shares under <U>Section&nbsp;6.4(d)</U>;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(h)</TD><TD STYLE="text-align: justify">to determine whether a Stock Option is an ISO or Nonstatutory Stock Option;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">to impose a &ldquo;blackout&rdquo; period during which Stock Options may not be exercised;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(j)</TD><TD STYLE="text-align: justify">to determine whether to require a Participant, as a condition of the granting of any Award, to not sell
or otherwise dispose of Shares acquired upon the exercise of an Award for a period of time as determined by the Committee after the date
of the acquisition of such Award;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(k)</TD><TD STYLE="text-align: justify">to modify, extend, or renew an Award, subject to <U>Section&nbsp;6.4(l)</U> and <U>Article&nbsp;XII</U>;
and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(l)</TD><TD STYLE="text-align: justify">solely to the extent permitted by Applicable Law, to determine whether, to what extent, and under what
circumstances to provide loans (which may be on a recourse basis and bear interest at the rate the Committee may determine) to Participants
in order to exercise Stock Options.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>3.3</B></TD><TD STYLE="text-align: justify"><B><U>Guidelines</U></B>. Subject to <U>Article&nbsp;XII</U>, the Committee will have the authority to
adopt, alter, and repeal such administrative rules, guidelines, and practices governing the Plan and perform all acts, including the delegation
of its responsibilities (to the extent permitted by Applicable Law), as it may deem advisable; to construe and interpret the Plan, all
Awards, and all Award Agreements (and in each case any agreements relating thereto); and to otherwise supervise the administration of
the Plan. The Committee may correct any defect, supply any omission, or reconcile any inconsistency in the Plan or in any agreement relating
thereto in the manner and to the extent it deems necessary to effectuate the purpose and intent of the Plan. The Committee may adopt special
terms and conditions for Persons who are residing in, or employed in, or subject to the taxes of, any domestic or foreign jurisdictions
to comply with Applicable Law. Notwithstanding the foregoing terms and conditions of this <U>Section&nbsp;3.3</U>, no action of the Committee
under this <U>Section&nbsp;3.3</U> may substantially impair the rights of any Participant without the Participant&rsquo;s consent. To
the extent applicable, the Plan is intended to comply with the applicable requirements of Rule 16b-3, and the Plan will be limited, construed,
and interpreted in a manner so as to comply therewith.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>3.4</B></TD><TD STYLE="text-align: justify"><B><U>Sole Discretion; Decisions Final</U></B>. Any decision, interpretation, or other action made or
taken by or at the direction of the Company, the Board, or the Committee (or any of their members) arising out of or in connection with
the Plan will be within the sole and absolute discretion of all and each of them, as the case may be, and will be final, binding, and
conclusive on the Company and all employees and Participants and their respective heirs, executors, administrators, successors, and assigns
and all other Persons having an interest in the Plan.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>3.5</B></TD><TD><B><U>Designation of Consultants/Liability</U></B>.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">The Committee may designate employees of the Company and professional advisors to assist the Committee
in the administration of the Plan and may grant authority to officers to grant Awards and execute agreements and other documents on behalf
of the Committee, in each case to the extent permitted by Applicable Law. In the event of any designation of authority hereunder, subject
to Applicable Law and any terms and conditions imposed by the Committee in connection with such designation, such designee or designees
will have the power and authority to take such actions, exercise such powers, and make such determinations that are otherwise specifically
designated to the Committee hereunder.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">The Committee may employ such legal counsel, consultants, and agents as it may deem desirable for the
administration of the Plan and may rely upon any opinion received from any such counsel or consultant and any computation received from
any such consultant or agent. Expenses incurred by the Committee or the Board in the engagement of any such counsel, consultant, or agent
will be paid by the Company. The Committee, its members, and any Person designated under <U>Section&nbsp;3.5(a)</U> will not be liable
for any action or determination made in good faith with respect to the Plan. To the maximum extent permitted by Applicable Law, no officer
of the Company or member or former member of the Committee or of the Board will be liable for any action or determination made in good
faith with respect to the Plan or any Award.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>3.6</B></TD><TD STYLE="text-align: justify"><B><U>Indemnification</U></B>. To the maximum extent permitted by Applicable Law and the Certificate of
Incorporation and By-Laws of the Company and to the extent not covered by insurance directly insuring such Person, each officer and employee
of the Company and each Affiliate and member or former member of the Committee and the Board will be indemnified and held harmless by
the Company against all costs and expenses and liabilities, and advanced amounts necessary to pay the foregoing at the earliest time and
to the fullest extent permitted, arising out of any act or omission to act in connection with the administration of the Plan, except to
the extent arising out of such officer&rsquo;s, employee&rsquo;s, member&rsquo;s, or former member&rsquo;s own fraud or bad faith. Such
indemnification will be in addition to any right of indemnification the employees, officers, directors, or members or former officers,
directors, or members may have under Applicable Law or under the Certificate of Incorporation or By-Laws of the Company or an Affiliate.
Notwithstanding any other term or condition of the Plan, this indemnification will not apply to the actions or determinations made by
an individual with regard to Awards granted to himself or herself.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: uppercase"><B>Article
IV</B></FONT><BR>
<B>SHARE LIMITATION</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>4.1</B></TD><TD STYLE="text-align: justify"><B><U>Shares</U></B>.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify"><U>Share Limits and Counting</U>. The maximum number of Shares available for issuance under the Plan may
not exceed the sum of (i) 26,250,709 Shares and (ii) 21,888,258 Shares issued pursuant to Restricted Shares in connection with the Registration
Date (such sum, subject to any increase or decrease under this <U>Section&nbsp;4.1</U> or <U>Section&nbsp;4.2</U>, the <B>&ldquo;<U>Share
Reserve</U>&rdquo;</B>). The Share Reserve may consist of authorized and unissued Shares and Shares held in or acquired for the treasury
of the Company. The Share Reserve will automatically increase on each January 1 that occurs after the Effective Date, for 10 years, by
an amount equal to 5% of the total number of Shares outstanding on December 31 of the preceding calendar year, or a lesser number as may
be determined by the Board. The maximum number of Shares with respect to which ISOs may be granted is 26,250,709 Shares. With respect
to Stock Appreciation Rights settled in Shares, upon settlement, only the number of Shares delivered to a Participant will count against
the Share Reserve. If any Stock Option, Stock Appreciation Right, or Other Share-Based Award expires, terminates, or is canceled for any
reason without having been exercised in full, the number of Shares underlying such Award will be added back to the Share Reserve. If any
Restricted Shares, Performance Awards, or Other Share-Based Awards denominated in Shares are forfeited for any reason, the number of Shares
underlying such Award will be added back to the Share Reserve. Any Award settled in cash will not count against the Share Reserve. If
Shares issuable upon exercise, vesting, or settlement of an Award are surrendered or tendered to the Company in payment of the purchase
or exercise price of an Award or any taxes required to be withheld in respect of an Award, in each case, in accordance with the terms
of the Plan, such surrendered or tendered Shares will be added back to the Share Reserve. Awards may be granted in assumption of, or in
substitution for, outstanding awards previously granted by an entity acquired by the Company or with which the Company combines (<B>&ldquo;<U>Substitute
Awards</U>&rdquo;</B>). Substitute Awards will not count against the Share Reserve; <U>provided</U>, that Substitute Awards issued in
connection with the assumption of, or in substitution for, outstanding Stock Options intended to qualify as ISOs will count against the
ISO limit above. Subject to applicable stock exchange requirements, available shares under a shareholder-approved plan of an entity acquired
by the Company or with which the Company combines (as appropriately adjusted to reflect such acquisition or transaction) may be used for
Awards and will not count against the Share Reserve.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify"><U>Annual Non-Employee Director Award Limitation</U>. The maximum value of Awards granted during any calendar
year to any Non-Employee Director, taken together with any cash fees paid to that Non-Employee Director during the calendar year and the
value of awards granted to the Non-Employee Director under any other compensation plan of the Company or any Affiliate during the calendar
year, may not exceed $750,000 in total value (based on the Fair Market Value of the Shares underlying the Award as of the grant date for
Restricted Shares and Other Share-Based Awards, and based on the grant date fair value for accounting purposes for Stock Options and Stock
Appreciation Rights).</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>4.2</B></TD><TD><B><U>Changes</U></B>.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">The existence of the Plan and any Awards will not affect in any way the right or power of the Board, the
Committee, or the Stockholders to make or authorize (i)&nbsp;any adjustment, recapitalization, reorganization, or other change in the
Company&rsquo;s capital structure or its business, (ii)&nbsp;any merger or consolidation of the Company or any Affiliate, (iii)&nbsp;any
issuance of bonds, debentures, preferred, or prior preference stock ahead of or affecting the Common Stock, (iv)&nbsp;the dissolution
or liquidation of the Company or any Affiliate, (v)&nbsp;any sale or transfer of all or part of the assets or business of the Company
or any Affiliate, or (vi)&nbsp;any other corporate act or proceeding.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">Subject to <U>Section&nbsp;11.1</U>:</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">In the event of any change in the outstanding Common Stock or in the capital structure of the Company
by reason of any stock split, reverse stock split, recapitalization, reorganization, merger, consolidation, combination, division, exchange,
spin off, extraordinary cash or stock dividend, or other relevant change in capitalization, Awards will be equitably adjusted or substituted
to the extent necessary to preserve the economic intent of such Awards.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">Fractional Shares resulting from any adjustment in Awards under this <U>Section&nbsp;4.2(b)</U> will be
aggregated until, and eliminated at, the time of exercise or payment by rounding down to the nearest whole number. No cash settlements
will be required with respect to fractional Shares eliminated by rounding. Notice of any adjustment will be given by the Committee to
each Participant whose Award has been adjusted and such adjustment (whether or not such notice is given) will be effective and binding
for all purposes of the Plan.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>4.3</B></TD><TD STYLE="text-align: justify"><B><U>Minimum Purchase Price</U></B>. Notwithstanding any other term or condition of the Plan, if authorized
but previously unissued Shares are issued under the Plan, such Shares may not be issued for a consideration that is less than as permitted
under Applicable Law.</TD></TR></TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: uppercase"><B>Article
V</B></FONT><BR>
<B>ELIGIBILITY</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>5.1</B></TD><TD STYLE="text-align: justify"><B><U>General Eligibility</U></B>. All current and prospective Eligible Individuals are eligible to be
granted Awards. Eligibility for the grant of Awards and actual participation in the Plan will be determined by the Committee.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>5.2</B></TD><TD STYLE="text-align: justify"><B><U>ISOs</U></B>. Notwithstanding <U>Section&nbsp;5.1</U>, only Eligible Employees of the Company, its
Subsidiaries, and any Parent are eligible to be granted ISOs.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>5.3</B></TD><TD STYLE="text-align: justify"><B><U>General Requirement</U></B>. The vesting and exercise of Awards granted to a prospective Eligible
Individual must be conditioned upon such individual actually becoming an Eligible Employee, Consultant, or Non-Employee Director, respectively.</TD></TR></TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: uppercase"><B>Article
VI</B></FONT><BR>
<B>STOCK OPTIONS</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>6.1</B></TD><TD STYLE="text-align: justify"><B><U>Stock Options</U></B>. Stock Options may be granted alone or in addition to other Awards. Each Stock
Option will be of 1 of 2 types: (a)&nbsp;an ISO or (b)&nbsp;a Nonstatutory Stock Option.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>6.2</B></TD><TD STYLE="text-align: justify"><B><U>Grants</U></B>. The Committee will have the authority to grant to any Eligible Employee 1 or more
ISOs, Nonstatutory Stock Options, or both types of Stock Options. The Committee will have the authority to grant any Consultant or Non-Employee
Director 1 or more Nonstatutory Stock Options. To the extent that any Stock Option does not qualify as an ISO, such Stock Option or the
portion thereof that does not so qualify will constitute a separate Nonstatutory Stock Option.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>6.3</B></TD><TD STYLE="text-align: justify"><B><U>ISOs</U></B>. Notwithstanding any other term or condition of the Plan, no term or condition of the
Plan relating to ISOs will be interpreted, amended, or altered, nor will any discretion or authority granted under the Plan be so exercised,
so as to disqualify the Plan under Code Section&nbsp;422, or, without the consent of the Participants affected, to disqualify any ISO
under Code Section&nbsp;422.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>6.4</B></TD><TD STYLE="text-align: justify"><B><U>Terms and Conditions of Stock Options</U></B>. Stock Options will be subject to terms and conditions,
not inconsistent with the Plan, determined by the Committee, and the following:</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify"><U>Exercise Price</U>. The exercise price per Share subject to a Stock Option will be determined by the
Committee at the time of grant, <U>provided</U> that the per Share exercise price of a Stock Option may not be less than 100% (or, in
the case of an ISO granted to a Ten Percent Stockholder, 110%) of the Fair Market Value of the Common Stock at the grant date.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify"><U>Stock Option Term</U>. The term of each Stock Option will be fixed by the Committee, <U>provided</U>
that no Stock Option may be exercisable more than 10 years after the date the Stock Option is granted; and <U>provided further</U> that
the term of an ISO granted to a Ten Percent Stockholder may not exceed 5 years.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify"><U>Exercisability</U>. Unless otherwise determined by the Committee in accordance with this <U>Section&nbsp;6.4</U>,
Stock Options will be exercisable at the time or times and subject to the terms and conditions determined by the Committee at the time
of grant. If the Committee provides that any Stock Option is exercisable subject to certain terms and conditions, the Committee may waive
those terms and conditions on the exercisability at any time at or after the time of grant in whole or in part.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify"><U>Method of Exercise</U>. Subject to whatever installment exercise and waiting period terms and conditions
that may apply under <U>Section&nbsp;6.4(c)</U>, to the extent vested, Stock Options may be exercised in whole or in part at any time
during the Stock Option term by giving written notice of exercise to the Company specifying the number of Shares to be purchased. </TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0"></P>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&nbsp;</TD><TD STYLE="text-align: justify">Such notice must be accompanied by
payment in full of the exercise price as follows: (i)&nbsp;in cash or by check, bank draft, or money order payable to the order of the
Company; (ii)&nbsp;solely to the extent permitted by Applicable Law, if the Common Stock is listed on a national stock exchange, and
the Committee authorizes, through a procedure whereby the Participant delivers irrevocable instructions to a broker reasonably acceptable
to the Committee to deliver promptly to the Company an amount equal to the exercise price; (iii)&nbsp;to the extent the Committee authorizes,
having the Company withhold Shares issuable upon exercise of the Stock Option, or by payment in full or in part in the form of Shares
owned by the Participant, based on the Fair Market Value of the Shares on the payment date; or (iv)&nbsp;on such other terms and conditions
that may be acceptable to the Committee. No Shares will be issued under the Plan until payment for those Shares has been made or provided
for in accordance with the Plan.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD STYLE="text-align: justify"><U>Non-Transferability of Stock Options</U>. No Stock Option will be Transferable by the Participant other
than by will or by the laws of descent and distribution, and all Stock Options will be exercisable, during the Participant&rsquo;s lifetime,
only by the Participant, except that the Committee may determine at the time of grant or thereafter that a Nonstatutory Stock Option that
is otherwise not Transferable under this <U>Section&nbsp;6.4(e)</U> is Transferable to a Family Member in whole or in part on terms and
conditions that are specified by the Committee. A Nonstatutory Stock Option that is Transferred to a Family Member under the preceding
sentence (i)&nbsp;may not be subsequently Transferred other than by will or by the laws of descent and distribution and (ii)&nbsp;remains
subject to the Plan and the applicable Award Agreement. Any Shares acquired upon the exercise of a Nonstatutory Stock Option by a permissible
transferee of a Nonstatutory Stock Option or a permissible transferee under a Transfer after the exercise of the Nonstatutory Stock Option
will be subject to the Plan and the applicable Award Agreement.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(f)</TD><TD STYLE="text-align: justify"><U>Separation from Service by Death or Disability</U>. Unless otherwise determined by the Committee at
the time of grant, or if no rights of the Participant are reduced, thereafter, if a Participant&rsquo;s Separation from Service is by
reason of death or Disability, all Stock Options that are held by such Participant that are vested and exercisable at the time of the
Participant&rsquo;s Separation from Service may be exercised by the Participant (or in the case of the Participant&rsquo;s death, by the
legal representative of the Participant&rsquo;s estate) at any time within a period of 1 year from the date of such Separation from Service,
but in no event beyond the expiration of the stated term of such Stock Options; <U>provided</U>, <U>however</U>, that, in the event of
a Participant&rsquo;s Separation from Service by reason of Disability, if the Participant dies within such exercise period, all unexercised
Stock Options held by such Participant will thereafter be exercisable, to the extent to which they were exercisable at the time of death,
for a period of 1 year from the date of such death, but in no event beyond the expiration of the stated term of such Stock Options.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(g)</TD><TD STYLE="text-align: justify"><U>Involuntary Separation from Service without Cause</U>. Unless otherwise determined by the Committee
at the time of grant, or if no rights of the Participant are reduced, thereafter, if a Participant&rsquo;s Separation from Service is
initiated by the Company without Cause, all Stock Options that are held by such Participant that are vested and exercisable at the time
of the Participant&rsquo;s Separation from Service may be exercised by the Participant at any time within a period of 90 days after the
date of such Separation from Service, but in no event beyond the expiration of the stated term of such Stock Options.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(h)</TD><TD STYLE="text-align: justify"><U>Voluntary Resignation</U>. Unless otherwise determined by the Committee at the time of grant, or if
no rights of the Participant are reduced, thereafter, if a Participant&rsquo;s Separation from Service is voluntary (other than a voluntary
Separation from Service described in <U>Section&nbsp;6.4(i)(y)</U>), all Stock Options that are held by such Participant that are vested
and exercisable at the time of the Participant&rsquo;s Separation from Service may be exercised by the Participant at any time within
a period of 90 days from the date of such Separation from Service, but in no event beyond the expiration of the stated term of such Stock
Options.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify"><U>Separation from Service for Cause</U>. Unless otherwise determined by the Committee at the time of
grant, or if no rights of the Participant are reduced, thereafter, if a Participant&rsquo;s Separation from Service (x) is for Cause or
(y) is a voluntary Separation from Service (as provided in <U>Section&nbsp;6.4(h)</U>) after the occurrence of an event that would be
grounds for a Separation from Service for Cause, all Stock Options, whether vested or not vested, that are held by such Participant will
terminate and expire as of the date of such Separation from Service.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(j)</TD><TD STYLE="text-align: justify"><U>Unvested Stock Options</U>. Unless otherwise determined by the Committee at the time of grant, or if
no rights of the Participant are reduced, thereafter, Stock Options that are not vested as of the date of a Participant&rsquo;s Separation
from Service for any reason will terminate and expire as of the date of such Separation from Service.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(k)</TD><TD STYLE="text-align: justify"><U>ISO Terms and Conditions</U>. To the extent that the aggregate Fair Market Value (determined as of
the time of grant) of the Common Stock with respect to which ISOs are exercisable for the first time by an Eligible Employee during any
calendar year under the Plan or any other stock option plan of the Company, any Subsidiary, or any Parent exceeds $100,000, such Stock
Options will be treated as Nonstatutory Stock Options. In addition, if an Eligible Employee does not remain employed by the Company, any
Subsidiary, or any Parent at all times from the time an ISO is granted until 3 months before the date of exercise thereof (or such other
period as required by Applicable Law), such Stock Option will be treated as a Nonstatutory Stock Option. Should any term or condition
of the Plan not be necessary in order for the Stock Options to qualify as ISOs, or should any additional terms and conditions be required,
the Committee may amend the Plan accordingly.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(l)</TD><TD STYLE="text-align: justify"><U>Form, Modification, Extension and Renewal
of Stock Options</U>. Subject to the terms and conditions of the Plan, Stock Options will be evidenced by such form of agreement or grant
as is approved by the Committee, and the Committee may (i)&nbsp;modify, extend, or renew outstanding Stock Options (<U>provided</U> that
the rights of a Participant are not reduced without such Participant&rsquo;s consent; and <U>provided</U>, <U>further</U>, that such
action does not subject the Stock Options to Section&nbsp;409A without the consent of the Participant), and (ii)&nbsp;accept the surrender
of outstanding Stock Options (to the extent not theretofore exercised) and authorize the granting of new Stock Options in substitution
therefor (to the extent not theretofore exercised).</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&nbsp;</TD><TD STYLE="text-align: justify">Notwithstanding
any other term or condition of the Plan, except in connection with a corporate transaction involving the Company in accordance with <U>Section&nbsp;4.2</U>,
the repricing of Options (and Stock Appreciation Rights) is prohibited without prior approval of the Stockholders. For this purpose, a
&ldquo;repricing&rdquo; means any of the following (or any other action that has the same effect as any of the following): (y)&nbsp;any
action that is treated as a &ldquo;repricing&rdquo; under GAAP and (z)&nbsp;repurchasing for cash or canceling an Option or a Stock Appreciation
Right at a time when its exercise price is greater than the Fair Market Value of the underlying Shares in exchange for another Award.
A cancellation and exchange under clause (z)&nbsp;would be considered a &ldquo;repricing&rdquo; regardless of whether it is treated as
a &ldquo;repricing&rdquo; under GAAP and regardless of whether it is voluntary on the part of the Participant.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(m)</TD><TD STYLE="text-align: justify"><U>Early Exercise</U>. The Committee may provide that a Stock Option include a term or condition whereby
the Participant may elect at any time before the Participant&rsquo;s Separation from Service to exercise the Stock Option as to any part
or all of the Shares subject to the Stock Option before the full vesting of the Stock Option and such Shares will be subject to the terms
and conditions of <U>Article VIII</U> and be treated as Restricted Shares. Unvested Shares so exercised may be subject to a repurchase
option in favor of the Company or to any other restriction the Committee may determine.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(n)</TD><TD STYLE="text-align: justify"><U>Automatic Exercise</U>. The Committee may include a term or condition in an Award Agreement providing
for the automatic exercise of a Nonstatutory Stock Option on a cashless basis on the last day of the term of such Stock Option if the
Participant has failed to exercise the Nonstatutory Stock Option as of such date, with respect to which the Fair Market Value of the Shares
underlying the Nonstatutory Stock Option exceeds the exercise price of such Nonstatutory Stock Option on the date of expiration of such
Stock Option, subject to <U>Section&nbsp;13.5</U>.</TD></TR></TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: uppercase"><B>Article
VII</B></FONT><BR>
<B>STOCK APPRECIATION RIGHTS</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>7.1</B></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><U>Terms and Conditions of Stock Appreciation
Rights</U></B></FONT>. Stock Appreciation Rights will be subject to terms and conditions, not inconsistent with the Plan, determined by
the Committee, and the following:</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify"><U>Exercise Price</U>. The exercise price per Share subject to a Stock Appreciation Right will be determined
by the Committee at the time of grant</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify"><U>Term</U>. The term of each Stock Appreciation Right will be fixed by the Committee, but may not be
greater than 10 years after the date the right is granted.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify"><U>Exercisability</U>. Unless otherwise determined by the Committee in accordance with this <U>Section&nbsp;7.1</U>,
Stock Appreciation Rights will be exercisable at the time or times and subject to the terms and conditions determined by the Committee
at the time of grant. If the Committee provides that any such right is exercisable subject to certain terms and conditions, the Committee
may waive those terms and conditions on the exercisability at any time at or after grant in whole or in part.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify"><U>Method of Exercise</U>. Subject to whatever installment exercise and waiting period terms and conditions
apply under <U>Section&nbsp;7.1(c)</U>, Stock Appreciation Rights may be exercised in whole or in part at any time in accordance with
the applicable Award Agreement, by giving written notice of exercise to the Company specifying the number of Stock Appreciation Rights
to be exercised.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD STYLE="text-align: justify"><U>Payment</U>. Upon the exercise of a Stock Appreciation Right, a Participant will be entitled to receive,
for each right exercised, up to, but no more than, an amount in cash or Common Stock (as chosen by the Committee) equal in value to the
excess of the Fair Market Value of 1 Share on the date that the right is exercised over the Fair Market Value of 1 Share on the date that
the right was awarded to the Participant.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(f)</TD><TD STYLE="text-align: justify"><U>Separation from Service</U>. Unless otherwise determined by the Committee at the time of grant or,
if no rights of the Participant are reduced, thereafter, subject to the applicable Award Agreement and the Plan, upon a Participant&rsquo;s
Separation from Service for any reason, Stock Appreciation Rights will remain exercisable after a Participant&rsquo;s Separation from
Service on the same basis as Stock Options would be exercisable after a Participant&rsquo;s Separation from Service in accordance with
<U>Sections&nbsp;6.4(f)</U> through <U>6.4(j)</U>.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(g)</TD><TD STYLE="text-align: justify"><U>Non-Transferability</U>. No Stock Appreciation Rights will be Transferable by the Participant other
than by will or by the laws of descent and distribution, and all such rights will be exercisable, during the Participant&rsquo;s lifetime,
only by the Participant.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>7.2</B></TD><TD STYLE="text-align: justify"><B><U>Automatic Exercise</U></B>. The Committee may include a term or condition in an Award Agreement
providing for the automatic exercise of a Stock Appreciation Right on a cashless basis on the last day of the term of the Stock Appreciation
Right if the Participant has failed to exercise the Stock Appreciation Right as of such date, with respect to which the Fair Market Value
of the Shares underlying the Stock Appreciation Right exceeds the exercise price of such Stock Appreciation Right on the date of expiration
of such Stock Appreciation Right, subject to <U>Section&nbsp;13.5</U>.</TD></TR></TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: uppercase"><B>Article
VIII</B></FONT><BR>
<B>RESTRICTED SHARES</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>8.1</B></TD><TD STYLE="text-align: justify"><B><U>Restricted Shares</U></B>. Restricted Shares may be issued either alone or in addition to other
Awards. The Committee will determine the Eligible Individuals, to whom, and the time or times at which, grants of Restricted Shares will
be made, the number of Restricted Shares to be awarded, the price (if any) to be paid by the Participant (subject to <U>Section&nbsp;8.2</U>),
the time or times within which such Awards will be subject to forfeiture, the vesting schedule and rights to acceleration thereof, and
all other terms and conditions of the Awards.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>8.2</B></TD><TD STYLE="text-align: justify"><B><U>Awards and Certificates</U></B>. Participants selected to receive Restricted Shares will not have
any right with respect to the Award, unless and until the Participant has delivered a fully executed copy of the agreement evidencing
the Award to the Company, to the extent required by the Committee, and has otherwise complied with the applicable terms and conditions
of the Award. Further, such Award will be subject to the following:</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify"><U>Purchase Price</U>. The purchase price of Restricted Shares will be fixed by the Committee. Subject
to <U>Section&nbsp;4.3</U>, the purchase price for Restricted Shares may be zero to the extent permitted by Applicable Law, and, to the
extent required by Applicable Law, such purchase price may not be less than par value.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify"><U>Legend</U>. Each Participant receiving Restricted Shares will be issued a stock certificate in respect
of the Restricted Shares, unless the Committee elects to use another system, such as book entries by the transfer agent, as evidencing
ownership of Restricted Shares. Such certificate will be registered in the name of the Participant, and will, in addition to any legends
required by Applicable Law, bear an appropriate legend referring to the terms and conditions applicable to the Award, substantially in
the following form:</TD></TR></TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0.25in 12pt 1.25in; text-align: justify">&ldquo;The anticipation, alienation,
attachment, sale, transfer, assignment, pledge, encumbrance, or charge of the restricted shares of stock represented hereby are subject
to the terms and conditions (including forfeiture) of the Oak Street Health, Inc. (the &ldquo;Company&rdquo;) Omnibus Incentive Plan (the
&ldquo;Plan&rdquo;) and an award agreement entered into between the registered owner and the Company dated __________ (the &ldquo;Agreement&rdquo;).
Copies of such Plan and Agreement are on file at the principal office of the Company.&rdquo;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify"><U>Custody</U>. If stock certificates are issued in respect of Restricted Shares, the Committee may require
that any stock certificates evidencing such Shares be held in custody by the Company until the restrictions thereon have lapsed, and that,
as a condition of any grant of Restricted Shares, the Participant must deliver a duly signed stock power or other instruments of assignment,
each endorsed in blank with a guarantee of signature if deemed necessary or appropriate by the Company, which would permit transfer to
the Company of all or a portion of the Restricted Shares in the event that such Award is forfeited in whole or part.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>8.3</B></TD><TD STYLE="text-align: justify"><B><U>Terms and Conditions</U></B>. Restricted Shares will be subject to terms and conditions, not inconsistent
with the Plan, determined by the Committee, and the following:</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify"><U>Restriction Period</U>. The Participant is not permitted to Transfer Restricted Shares during the period
or periods set by the Committee (the <B>&ldquo;<U>Restriction Period</U>&rdquo;</B>) commencing on the date of such Award, as set forth
in the applicable Award Agreement, and such agreement will set forth a vesting schedule and any event that would accelerate vesting of
the Restricted Shares. Within these limits, based on service, attainment of Performance Goals, or such other factors or criteria as the
Committee may determine, the Committee may condition the grant or provide for the lapse of such restrictions in installments in whole
or in part, or may accelerate the vesting of all or any part of any Restricted Shares and waive the deferral terms and conditions for
all or any part of any Restricted Shares.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify"><U>Rights as a Stockholder</U>. Except as provided in <U>Section&nbsp;8.3(a)</U> and this <U>Section&nbsp;8.3(b)</U>
or as otherwise determined by the Committee, the Participant will have, with respect to Restricted Shares, all of the rights of a Stockholder,
including the right to receive dividends, the right to vote such Restricted Shares, and, subject to and conditioned upon the full vesting
of Restricted Shares, the right to tender those Shares. The Committee may determine at the time of grant that the payment of dividends
will be deferred until, and conditioned upon, the expiration of the applicable Restriction Period.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify"><U>Separation from Service</U>. Unless otherwise determined by the Committee at the time of grant or,
if no rights of the Participant are reduced, thereafter, subject to the applicable Award Agreement and the Plan, upon a Participant&rsquo;s
Separation from Service for any reason during the relevant Restriction Period, all Restricted Shares will be forfeited.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify"><U>Lapse of Restrictions</U>. If and when the Restriction Period expires without a prior forfeiture of
the Restricted Shares, the certificates for such Shares will be delivered to the Participant. All legends will be removed from said certificates
at the time of delivery to the Participant, except as otherwise required by Applicable Law or other terms and conditions imposed by the
Committee.</TD></TR></TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: uppercase"><B>Article
IX</B></FONT><BR>
<B>PERFORMANCE AWARDS</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>9.1</B></TD><TD STYLE="text-align: justify"><B><U>Performance Awards</U></B>. The Committee may grant a Performance Award to a Participant payable
upon the attainment of specific Performance Goals. If the Performance Award is payable in Restricted Shares, such Shares will be transferable
to the Participant only upon attainment of the relevant Performance Goal in accordance with <U>Article VIII</U>. If the Performance Award
is payable in cash, it may be paid upon the attainment of the relevant Performance Goals either in cash or in Restricted Shares (based
on the then current Fair Market Value of such Shares). Each Performance Award will be evidenced by an Award Agreement in such form that
is not inconsistent with the Plan and that the Committee may approve. The Committee will condition the right to payment of any Performance
Award upon the attainment of objective Performance Goals established under <U>Section&nbsp;9.2(c)</U>.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>9.2</B></TD><TD STYLE="text-align: justify"><B><U>Terms and Conditions</U></B>. Performance Awards will be subject to terms and conditions, not inconsistent
with the Plan, determined by the Committee, and the following:</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify"><U>Earning of Performance Award</U>. At the expiration of the applicable Performance Period, the Committee
will determine the extent to which the Performance Goals established under <U>Section&nbsp;9.2(c)</U> are achieved and the percentage
of each Performance Award that has been earned.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify"><U>Non-Transferability</U>. Subject to the applicable Award Agreement and the Plan, Performance Awards
may not be Transferred.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify"><U>Objective Performance Goals, Formulae or Standards</U>. The Committee will establish the objective
Performance Goals for the earning of Performance Awards based on a Performance Period applicable to each Participant or class of Participants
in writing before the beginning of the applicable Performance Period or at such later date while the outcome of the Performance Goals
is substantially uncertain. Such Performance Goals may incorporate terms and conditions for disregarding (or adjusting for) changes in
accounting methods, corporate transactions, and other similar type events or circumstances.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify"><U>Dividends</U>. Unless otherwise determined by the Committee at the time of grant, amounts equal to
dividends declared during the Performance Period with respect to the number of Shares covered by a Performance Award will not be paid
to the Participant.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD STYLE="text-align: justify"><U>Payment</U>. After the Committee&rsquo;s determination in accordance with <U>Section&nbsp;9.2(a)</U>,
the Company will settle Performance Awards, in such form as determined by the Committee, in an amount equal to such Participant&rsquo;s
earned Performance Awards. Notwithstanding the foregoing sentence, the Committee may award an amount less than the earned Performance
Awards and subject the payment of all or part of any Performance Award to additional vesting, forfeiture, and deferral terms and conditions.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(f)</TD><TD STYLE="text-align: justify"><U>Separation from Service</U>. Subject to the applicable Award Agreement and the Plan, upon a Participant&rsquo;s
Separation from Service for any reason during the Performance Period for a Performance Award, the Performance Award will vest or be forfeited
in accordance with the terms and conditions established by the Committee at grant.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(g)</TD><TD STYLE="text-align: justify"><U>Accelerated Vesting</U>. Based on service, performance, and any other factors or criteria the Committee
may determine, the Committee may, at or after grant, accelerate the vesting of all or any part of any Performance Award.</TD></TR></TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: uppercase"><B>Article
X</B></FONT><BR>
<B>OTHER STOCK-BASED AND CASH-BASED AWARDS</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>10.1</B></TD><TD STYLE="text-align: justify"><B><U>Other Share-Based Awards</U></B>. The Committee is authorized to grant to Eligible Individuals Other
Share-Based Awards that are payable in, valued in whole or in part by reference to, or otherwise based on or related to Shares, including
Shares awarded purely as a bonus and not subject to terms or conditions, Shares in payment of the amounts due under an incentive or performance
plan sponsored or maintained by the Company or an Affiliate, stock equivalent units, restricted stock units (RSUs), and Awards valued
by reference to book value of Shares. Other Share-Based Awards may be granted either alone or in addition to or in tandem with other Awards.
Subject to the terms and conditions of the Plan, the Committee has the authority to determine the Eligible Individuals to whom, and the
time or times at which, Other Share-Based Awards will be granted, the number of Shares to be granted under such Awards, and all other
terms and conditions of the Awards.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>10.2</B></TD><TD STYLE="text-align: justify"><B><U>Terms and Conditions</U></B>. Other Share-Based Awards will be subject to terms and conditions,
not inconsistent with the Plan, determined by the Committee, and the following:</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify"><U>Non-Transferability</U>. Subject to the applicable Award Agreement and the Plan, Shares subject to
Other Share-Based Awards may not be Transferred before the date on which the Shares are issued, or, if later, the date on which any applicable
restriction, performance, or deferral period lapses.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify"><U>Dividends</U>. Unless otherwise determined by the Committee at the time of grant, subject to the applicable
Award Agreement and the Plan, the recipient of an Other Share-Based Award will not be entitled to receive, currently or on a deferred
basis, dividends or dividend equivalents in respect of the number of Shares covered by the Award.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify"><U>Vesting</U>. All Other Share-Based Awards and any Shares covered by those awards will vest or be forfeited
to the extent so provided in the Award Agreement.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify"><U>Price</U>. Common Stock issued on a bonus basis under this <U>Article X</U> may be issued for no cash
consideration. Common Stock purchased under a purchase right awarded under this <U>Article X</U> will be priced as determined by the Committee.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>10.3</B></TD><TD STYLE="text-align: justify"><B><U>Other Cash-Based Awards</U></B>. The Committee may grant Other Cash-Based Awards to Eligible Individuals
in amounts, on terms and conditions, and for consideration, including no consideration or such minimum consideration as may be required
by Applicable Law. Other Cash-Based Awards may be granted subject to the satisfaction of vesting terms and conditions or may be awarded
purely as a bonus and not subject to terms and conditions, and if subject to vesting, the Committee may accelerate such vesting at any
time.</TD></TR></TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: uppercase"><B>Article
XI</B></FONT><B><BR>
CHANGE IN CONTROL</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>11.1</B></TD><TD STYLE="text-align: justify"><B><U>Benefits</U></B>. In the event of a Change in Control (as defined below), and except as otherwise
determined by the Committee in an Award Agreement, a Participant&rsquo;s unvested Awards will not vest automatically and will be treated
in accordance with 1 or more of the following methods as determined by the Committee:</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">Awards, whether or not then vested, will be continued, assumed, or have new rights substituted therefor,
and restrictions to which Restricted Shares or any other Award granted before the Change in Control are subject will not lapse upon the
Change in Control and the Restricted Shares or other Awards will receive the same distribution as other Common Stock on terms and conditions
determined by the Committee, <U>provided</U> that the Committee may decide to award additional Restricted Shares or other Awards in lieu
of any cash distribution.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">The Committee may provide for the purchase of any Awards by the Company or an Affiliate for an amount
of cash equal to the excess (if any) of the Change in Control Price (as defined below) of the Shares covered by such Awards, over the
aggregate purchase or exercise price of such Awards. For purposes of the Plan, <B>&ldquo;<U>Change in Control Price</U>&rdquo;</B> means
the highest price per Share paid in any transaction related to a Change in Control.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">The Committee may terminate all outstanding and unexercised Stock Options, Stock Appreciation Rights,
and other Other Share-Based Awards that provide for a Participant-elected exercise, effective as of the Change in Control, by delivering
notice of termination to each Participant at least 20 days before the date of consummation of the Change in Control, in which case during
the period from the date on which such notice of termination is delivered to the consummation of the Change in Control, each affected
Participant will have the right to exercise in full all of the Participant&rsquo;s Awards that are then outstanding (without regard to
any terms and conditions on exercisability otherwise contained in the Award Agreements), but any such exercise will be contingent on the
occurrence of the Change in Control, and <U>provided</U> that if the Change in Control does not take place within a specified period after
giving such notice for any reason whatsoever, the notice and exercise pursuant thereto will be null and void.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">The Committee may make any other determination as to the treatment of Awards in connection with a Change
in Control. The treatment of Awards need not be the same for all Participants. Any escrow, holdback, earnout, or similar terms and conditions
in the definitive agreements relating to the Change in Control may apply to any payment to the holders of Awards to the same extent and
in the same manner as such terms and conditions apply to the holders of Shares.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>11.2</B></TD><TD STYLE="text-align: justify"><B><U>Change in Control</U></B>. Unless otherwise determined by the Committee in the applicable Award
Agreement or other written agreement with a Participant approved by the Committee, a <B>&ldquo;<U>Change in Control</U>&rdquo;</B> means:</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">any &ldquo;person,&rdquo; as that term is used in Sections 13(d) and 14(d) of the Exchange Act (other
than the Company, any trustee or other fiduciary holding securities under any employee benefit plan of the Company, or any company owned,
directly or indirectly, by the Stockholders in substantially the same proportions as their ownership of Common Stock), becomes the beneficial
owner (as defined in Rule 13d&#45;3 under the Exchange Act), directly or indirectly, of securities of the Company representing 50% or
more of the combined voting power of the Company&rsquo;s then outstanding securities;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">during any period of 24 consecutive calendar months, individuals who were directors serving on the Board
on the first day of such period (the <B>&ldquo;<U>Incumbent Directors</U>&rdquo;</B>) cease for any reason to constitute a majority of
the Board; <U>provided</U>, <U>however</U>, that any individual becoming a director after the first day of such period whose election,
or nomination for election, by the Stockholders was approved by a vote of at least 2/3 of the Incumbent Directors will be considered as
though such individual were an Incumbent Director, but excluding, for purposes of this proviso, any such individual whose initial assumption
of office occurs as a result of an actual or threatened proxy contest with respect to election or removal of directors or other actual
or threatened solicitation of proxies or consents by or on behalf of a &ldquo;person&rdquo; (as used in Section&nbsp;13(d) of the Exchange
Act), in each case other than the Board;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">consummation of a reorganization, merger, consolidation, or other business combination (any of the foregoing,
a <B>&ldquo;<U>Business Combination</U>&rdquo;</B>) of the Company or any direct or indirect subsidiary of the Company with any other
corporation, in any case with respect to which the Company voting securities outstanding immediately before such Business Combination
do not, immediately after such Business Combination, continue to represent (either by remaining outstanding or being converted into voting
securities of the Company or any ultimate parent thereof) more than 50% of the then outstanding voting securities entitled to vote generally
in the election of directors of the Company (or its successor) or any ultimate parent thereof after the Business Combination; or</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">a complete liquidation or dissolution of the Company or the consummation of a sale or disposition by the
Company of all or substantially all of the Company&rsquo;s assets other than the sale or disposition of all or substantially all of the
assets of the Company to a Person or Persons who beneficially own, directly or indirectly, 50% or more of the combined voting power of
the outstanding voting securities of the Company at the time of the sale.</TD></TR></TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0in">Notwithstanding the
foregoing terms and conditions of this definition, with respect to any Award that is characterized as &ldquo;nonqualified deferred compensation&rdquo;
within the meaning of Section&nbsp;409A, an event will not be considered to be a Change in Control under the Plan for purposes of payment
of such Award unless such event is also a &ldquo;change in control event&rdquo; within the meaning of Section&nbsp;409A.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>11.3</B></TD><TD STYLE="text-align: justify"><B><U>Initial Public Offering not a Change in Control</U></B>. Notwithstanding the foregoing terms and
conditions of the definition of Change in Control, the occurrence of the Registration Date or any change in the composition of the Board
within 1 year after the Registration Date will not be considered a Change in Control.</TD></TR></TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: uppercase"><B>Article
XII</B></FONT><B><BR>
AMENDMENT AND TERMINATION</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>12.1</B></TD><TD STYLE="text-align: justify"><B><U>Amendment and Termination of Plan</U></B>. Subject to <U>Section&nbsp;12.3</U>, the Board may amend
or terminate the Plan at any time; <U>provided</U>, <U>however</U>, that no amendment will be effective unless approved by the Stockholders
to the extent Stockholder approval is necessary to satisfy any Applicable Laws.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>12.2</B></TD><TD STYLE="text-align: justify"><B><U>Amendment of Awards</U></B>. Subject to <U>Section&nbsp;12.3</U>, the Committee may amend any Award
at any time; <U>provided</U>, <U>however</U>, that no amendment will be effective unless approved by the Stockholders to the extent Stockholder
approval is necessary to satisfy any Applicable Laws.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>12.3</B></TD><TD STYLE="text-align: justify"><B><U>No Impairment of Rights</U></B>. Rights under any Award granted before amendment or termination
of the Plan or amendment of an Award may not be substantially impaired by any such amendment or termination unless the Participant consents
in writing.</TD></TR></TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: uppercase"><B>Article
XIII</B></FONT><B><BR>
GENERAL TERMS AND CONDITIONS</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>13.1</B></TD><TD STYLE="text-align: justify"><B><U>Legend</U></B>. The Committee may require each person receiving Shares under the Plan to represent
to and agree with the Company in writing that the Participant is acquiring the Shares without a view to distribution thereof. In addition
to any legend required by the Plan, the certificates for Shares issued under the Plan may include any legend that the Committee deems
appropriate to reflect any restrictions on Transfer. All certificates for Shares delivered under the Plan will be subject to such stop
transfer orders and other restrictions as the Committee may deem advisable under Applicable Law, and the Committee may cause a legend
or legends to be put on any such certificates to make appropriate reference to such restrictions.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>13.2</B></TD><TD STYLE="text-align: justify"><B><U>Book Entry</U></B>. Notwithstanding any other term or condition of the Plan, the Company may elect
to satisfy any requirement under the Plan for the delivery of Share certificates through the use of another system, such as book entry.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>13.3</B></TD><TD STYLE="text-align: justify"><B><U>Other Plans</U></B>. Nothing contained in the Plan prevents the Board from adopting other or additional
compensation arrangements, subject to Stockholder approval if such approval is required, and such arrangements may be either generally
applicable or applicable only in specific cases.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>13.4</B></TD><TD STYLE="text-align: justify"><B><U>No Right to Employment/Consultancy/Directorship</U></B>. Neither the Plan nor the grant of any Award
gives any Person any right with respect to continuance of employment, consultancy, or directorship by the Company or any Affiliate, nor
does the Plan or the grant of any Award cause any limitation in any way on the right of the Company or any Affiliate by which an employee
is employed or a Consultant or Non-Employee Director is retained to terminate such employment, consultancy, or directorship at any time.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>13.5</B></TD><TD STYLE="text-align: justify"><B><U>Withholding for Taxes</U></B>. The Company or an Affiliate, as the case may be, has the right to
deduct from payments of any kind otherwise due to a Participant any federal, state, or local taxes of any kind required by Applicable
Law to be withheld (a)&nbsp;with respect to the vesting of or other lapse of restrictions applicable to an Award, (b)&nbsp;upon the issuance
of any Shares upon the exercise of an Option or Stock Appreciation Right, or (c)&nbsp;otherwise due in connection with an Award. At the
time the tax obligation becomes due, the Participant must pay to the Company or the Affiliate, as the case may be, any amount that the
Company or Affiliate determines to be necessary to satisfy the tax obligation. The Company or the Affiliate, as the case may be, may require
or permit the Participant to satisfy the tax obligation, in whole or in part, (i)&nbsp;by causing the Company or Affiliate to withhold
up to the maximum required number of Shares otherwise issuable to the Participant as may be necessary to satisfy such tax obligation or
(ii)&nbsp;by delivering to the Company or Affiliate Shares already owned by the Participant. The Shares so delivered or withheld must
have an aggregate Fair Market Value equal to the tax obligation.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>&nbsp;</B></TD><TD STYLE="text-align: justify">The Fair Market Value of the Shares used to satisfy the tax obligation
will be determined by the Company or the Affiliate as of the date that the amount of tax to be withheld is to be determined. To the extent
applicable, a Participant may satisfy his or her tax obligation only with Shares that are not subject to any repurchase, forfeiture, unfulfilled
vesting, or other similar requirements. Any fraction of a Share required to satisfy tax obligations will be disregarded and the amount
due must be paid instead in cash by the Participant.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>13.6</B></TD><TD STYLE="text-align: justify"><B><U>No Assignment of Benefits</U></B>. No Award or other benefit payable under the Plan may, except
as otherwise specifically provided by Applicable Law or permitted by the Committee, be Transferable in any manner, and any attempt to
Transfer any such benefit will be void, and any such benefit will not in any manner be liable for or subject to the debts, contracts,
liabilities, engagements, or torts of any Person who will be entitled to such benefit, nor will it be subject to attachment or legal process
for or against such Person.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>13.7</B></TD><TD><B><U>Listing and Other Terms and Conditions</U></B>.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">Unless otherwise determined by the Committee, as long as the Common Stock is listed on a national stock
exchange or system sponsored by a national securities association, the issuance of Shares under an Award will be conditioned upon such
Shares being listed on such exchange or system. The Company will have no obligation to issue such Shares unless and until such Shares
are so listed, and the right to exercise any Stock Option or other Award with respect to such Shares will be suspended until such listing
has been effected.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">If at any time counsel to the Company is of the opinion that any sale or delivery of Shares under an Award
is or may be unlawful or result in the imposition of excise taxes on the Company, the Company will have no obligation to make such sale
or delivery, or to make any application or to effect or to maintain any qualification or registration under the Securities Act or otherwise,
with respect to Shares or Awards, and the right to exercise any Stock Option or other Award will be suspended until, in the opinion of
said counsel, such sale or delivery would be lawful or would not result in the imposition of excise taxes on the Company.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">Upon termination of any period of suspension under this <U>Section&nbsp;13.7</U>, any Award affected by
such suspension that has not expired or terminated will be reinstated as to all Shares available before such suspension and as to Shares
that would otherwise have become available during the period of such suspension, but no such suspension will extend the term of any Award.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">A Participant will be required to supply the Company with certificates, representations, and information
that the Company requests and otherwise cooperate with the Company in obtaining any listing, registration, qualification, exemption, consent,
and approval the Company determines necessary or appropriate.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>13.8</B></TD><TD STYLE="text-align: justify"><B><U>Stockholders Agreement and Other Requirements</U></B>. Notwithstanding any other term or condition
of the Plan, as a condition to the receipt of Shares under an Award, to the extent required by the Committee, the Participant must execute
and deliver a Stockholder&rsquo;s agreement and such other documentation that sets forth certain restrictions on transferability of the
Shares acquired upon exercise or purchase, and such other terms and conditions as the Committee may establish. The Company may require,
as a condition of exercise, the Participant to become a party to any other existing Stockholder agreement (or other agreement).</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>13.9</B></TD><TD STYLE="text-align: justify"><B><U>Governing Law</U></B>. The Plan and actions taken in connection with the Plan will be governed and
construed in accordance with the laws of the State of Delaware (regardless of the law that might otherwise govern under applicable Delaware
principles of conflict of laws).</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>13.10</B></TD><TD STYLE="text-align: justify"><B><U>Jurisdiction; Waiver of Jury Trial</U></B>. Any suit, action, or proceeding with respect to the
Plan or any Award or Award Agreement, or any judgment entered by any court of competent jurisdiction in respect of the Plan or any Award
or Award Agreement, will be resolved only in the courts of the State of Delaware or the United States District Court for the District
of Delaware and the appellate courts having jurisdiction of appeals in such courts. In that context, and without limiting the generality
of the foregoing, each of the Company and each Participant irrevocably and unconditionally (a)&nbsp;submits in any proceeding relating
to the Plan or any Award or Award Agreement, or for the recognition and enforcement of any judgment in respect of the Plan or any Award
or Award Agreement (a <B>&ldquo;<U>Proceeding</U>&rdquo;</B>), to the exclusive jurisdiction of the courts of the State of Delaware or
the United States District Court for the District of Delaware and the appellate courts having jurisdiction of appeals in such courts,
and agrees that all claims in respect of any Proceeding will be heard and determined in such state court or, to the extent permitted by
Applicable Law, in such federal court, (b)&nbsp;consents that any Proceeding may and will be brought in such courts and waives any objection
that the Company or the Participant may have at any time after the Effective Date to the venue or jurisdiction of any Proceeding in any
such court or that the Proceeding was brought in an inconvenient court and agrees not to plead or claim the same, (c) waives all right
to trial by jury in any Proceeding (whether based on contract, tort, or otherwise) arising out of or relating to the Plan or any Award
or Award Agreement, (d)&nbsp;agrees that service of process in any Proceeding may be effected by mailing a copy of such process by registered
or certified mail (or any substantially similar form of mail), postage prepaid, to such party, in the case of a Participant, at the Participant&rsquo;s
address shown in the books and records of the Company or, in the case of the Company, at the Company&rsquo;s principal offices, attention
Chair of the Board, and (e)&nbsp;agrees that nothing in the Plan will affect the right to effect service of process in any other manner
permitted by the laws of the State of Delaware.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>13.11</B></TD><TD STYLE="text-align: justify"><B><U>Other Benefits</U></B>. No Award will be considered compensation for purposes of computing benefits
under any retirement plan of the Company or any Affiliate or affect any benefit under any other benefit plan now or subsequently in effect
under which the availability or amount of benefits is related to the level of compensation.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>13.12</B></TD><TD STYLE="text-align: justify"><B><U>Costs</U></B>. The Company will bear all expenses associated with administering the Plan, including
expenses of issuing Common Stock under Awards.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>13.13</B></TD><TD STYLE="text-align: justify"><B><U>No Right to Same Benefits</U></B>. The terms and conditions of Awards need not be the same with
respect to each Participant, and Awards to individual Participants need not be the same in subsequent years (if granted at all).</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>13.14</B></TD><TD STYLE="text-align: justify"><B><U>Death/Disability</U></B>. The Committee may require the transferee of a Participant to supply it
with written notice of the Participant&rsquo;s death or Disability and to supply it with a copy of the will (in the case of the Participant&rsquo;s
death) or such other evidence as the Committee deems necessary to establish the validity of the transfer of an Award. The Committee may
also require that the agreement of the transferee to be bound by the Plan.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>13.15</B></TD><TD STYLE="text-align: justify"><B><U>Section&nbsp;16(b) of the Exchange Act</U></B>. All elections and transactions under the Plan by
Persons subject to Section&nbsp;16 of the Exchange Act involving Shares are intended to comply with any applicable exemptive condition
under Rule&nbsp;16b-3. The Committee may establish and adopt written administrative guidelines, designed to facilitate compliance with
Section&nbsp;16(b) of the Exchange Act, as it may deem necessary or proper for the administration and operation of the Plan and the transaction
of business thereunder.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>13.16</B></TD><TD STYLE="text-align: justify"><B><U>Section&nbsp;409A</U></B>. The Plan is intended to comply Section&nbsp;409A and will be limited,
construed, and interpreted in accordance with such intent. To the extent that any Award is subject to Section&nbsp;409A, it will be paid
in a manner that complies with Section&nbsp;409A. Notwithstanding any other provision of the Plan, any Plan provision that is inconsistent
with Section&nbsp;409A will be deemed to be amended to comply with Section&nbsp;409A and to the extent such provision cannot be amended
to comply, such provision will be null and void. The Company will have no liability to a Participant, or any other party, if an Award
that is intended to be exempt from or compliant with Section&nbsp;409A is not so exempt or compliant, or for any action taken by the Committee
or the Company and, in the event that any amount or benefit under the Plan becomes subject to penalties under Section&nbsp;409A, responsibility
for payment of such penalties will rest solely with the affected Participants and not with the Company. Notwithstanding any other provision
in the Plan or any Award Agreement, any payment(s) of &ldquo;nonqualified deferred compensation&rdquo; (within the meaning of Section&nbsp;409A)
that are otherwise required to be made under the Plan to a &ldquo;specified employee&rdquo; (as defined under Section&nbsp;409A) as a
result of such employee&rsquo;s separation from service (other than a payment that is not subject to Section&nbsp;409A) will be delayed
for the first 6 months after such separation from service (or, if earlier, the date of death of the specified employee) and will instead
be paid (in a manner set forth in the Award Agreement) upon expiration of such delay period. All installment payments under the Plan will
be deemed separate payments for purposes of Section 409A.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>13.17</B></TD><TD STYLE="text-align: justify"><B><U>California Participants</U></B>. The Plan is intended to comply with Section 25102(o) of the California
Corporations Code, to the extent applicable. In that regard, to the extent required by Section&nbsp;25102(o), (a)&nbsp;the terms and conditions
of any Options and Stock Appreciation Rights, to the extent vested and exercisable upon a Participant&rsquo;s Separation from Service,
will include any minimum exercise periods after Separation from Service required by Section&nbsp;25102(o) and (b)&nbsp;any repurchase
right of the Company or any Affiliate will include a minimum 90-day notice requirement. Any Plan term that is inconsistent with Section&nbsp;25102(o)
will, without further act or amendment by the Company or the Board, be reformed to comply with the requirements of Section&nbsp;25102(o).</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>13.18</B></TD><TD STYLE="text-align: justify"><B><U>Successor and Assigns</U></B>. The Plan will be binding on all successors and permitted assigns
of a Participant, including the estate of such Participant and the executor, administrator, or trustee of such estate.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>13.19</B></TD><TD STYLE="text-align: justify"><B><U>Severability of Terms and Conditions</U></B>. If any term or condition of the Plan is held invalid
or unenforceable, such invalidity or unenforceability will not affect any other term or condition of the Plan, and the Plan will be construed
and enforced as if such term or condition had not been included.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>13.20</B></TD><TD STYLE="text-align: justify"><B><U>Payments to Minors, Etc</U></B>. Any benefit payable to or for the benefit of a minor, an incompetent
Person, or other Person incapable of receipt thereof will be considered paid when paid to such Person&rsquo;s guardian or to the party
providing or reasonably appearing to provide for the care of such Person, and such payment will fully discharge the Committee, the Board,
the Company, all Affiliates, and their employees, agents, and representatives with respect thereto.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>13.21</B></TD><TD STYLE="text-align: justify"><B><U>Lock-Up Agreement</U></B>. As a condition to the grant of an Award, if requested by the Company
and the lead underwriter of any public offering of Common Stock (the <B>&ldquo;<U>Lead Underwriter</U>&rdquo;</B><I>),</I> a Participant
must irrevocably agree not to sell, contract to sell, grant any option to purchase, transfer the economic risk of ownership in, make any
short sale of, pledge or otherwise transfer or dispose of, any interest in any Common Stock or any securities convertible into, derivative
of, or exchangeable or exercisable for, or any other rights to purchase or acquire Common Stock (except Common Stock included in such
public offering or acquired on the public market after such offering) during such period of time after the effective date of a registration
statement of the Company filed under the Securities Act that the Lead Underwriter may specify (the <B>&ldquo;<U>Lock&#45;Up Period</U>&rdquo;</B>).
Each Participant must sign such documents as may be requested by the Lead Underwriter to effect the foregoing. The Company may impose
stop-transfer instructions with respect to Common Stock acquired under an Award until the end of such Lock&#45;Up Period.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>13.22</B></TD><TD STYLE="text-align: justify"><B><U>Separation from Service for Cause; Clawbacks; Detrimental Conduct</U></B>.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify"><U>Separation from Service for Cause</U>. The Company may annul an Award if the Participant incurs a Separation
from Service for Cause.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify"><U>Clawbacks</U>. All awards, amounts, or benefits received or outstanding under the Plan will be subject
to clawback, cancellation, recoupment, rescission, payback, reduction, or other similar action in accordance with any Company clawback
or similar policy or any Applicable Law related to such actions. A Participant&rsquo;s acceptance of an Award will constitute the Participant&rsquo;s
acknowledgement of and consent to the Company&rsquo;s application, implementation, and enforcement of any applicable Company clawback
or similar policy that may apply to the Participant, whether adopted before or after the Effective Date, and any Applicable Law relating
to clawback, cancellation, recoupment, rescission, payback, or reduction of compensation, and the Participant&rsquo;s agreement that the
Company may take any actions that may be necessary to effectuate any such policy or Applicable Law, without further consideration or action.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify"><U>Detrimental Conduct</U>. Except as otherwise determined by the Committee, notwithstanding any other
term or condition of the Plan, if a Participant engages in Detrimental Conduct, whether during the Participant&rsquo;s service or after
the Participant&rsquo;s Separation from Service, in addition to any other penalties or restrictions that may apply under the Plan, Applicable
Law, or otherwise, the Participant must forfeit or pay to the Company the following:</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">any and all outstanding Awards granted to the Participant, including Awards that have become vested or
exercisable;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">any cash or Shares received by the Participant in connection with the Plan within the 36-month period
immediately before the date the Company determines the Participant has engaged in Detrimental Conduct; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD STYLE="text-align: justify">the profit realized by the Participant from the sale, or other disposition for consideration, of any Shares
received by the Participant under the Plan within the 36-month period immediately before the date the Company determines the Participant
has engaged in Detrimental Conduct.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>13.23</B></TD><TD STYLE="text-align: justify"><B><U>Data Protection</U></B>. A Participant&rsquo;s acceptance of an Award will be deemed to constitute
the Participant&rsquo;s acknowledgement of and consent to the collection and processing of personal data relating to the Participant so
that the Company and the Affiliates can fulfill their obligations and exercise their rights under the Plan and generally administer and
manage the Plan. This data will include data about participation in the Plan and Shares offered or received, purchased, or sold under
the Plan and other appropriate financial and other data (such as the date on which the Awards were granted) about the Participant and
the Participant&rsquo;s participation in the Plan.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>13.24</B></TD><TD STYLE="text-align: justify"><B><U>Unfunded Plan</U></B>. The Plan is intended to constitute an &ldquo;unfunded&rdquo; plan for incentive
and deferred compensation. With respect to any payment as to which a Participant has a fixed and vested interest but that is not yet made
to a Participant by the Company, nothing in the Plan gives any Participant any right that is greater than the rights of a general unsecured
creditor of the Company. The grant of an Award will not require a segregation of any of the Company&rsquo;s assets for satisfaction of
the Company&rsquo;s payment obligation under any Award.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>13.25</B></TD><TD><B><U>Plan Construction</U></B>. In the Plan, unless otherwise stated, the following uses apply:</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">references to Applicable Law refer to the Applicable Law and any amendments and supplements thereto and
any successor Applicable Law, and to all valid and binding rules and regulations promulgated thereunder, court decisions, and other regulatory
and judicial authority issued or rendered thereunder, as amended or supplemented, or their successors, as in effect at the relevant time;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">in computing periods from a specified date to a later specified date, the words &ldquo;from&rdquo; and
&ldquo;commencing on&rdquo; (and the like) mean &ldquo;from and including,&rdquo; and the words &ldquo;to,&rdquo; &ldquo;until,&rdquo;
and &ldquo;ending on&rdquo; (and the like) mean &ldquo;to and including&rdquo;;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">indications of time of day will be based upon the time applicable to the location of the principal headquarters
of the Company;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">the words &ldquo;include,&rdquo; &ldquo;includes,&rdquo; and &ldquo;including&rdquo; (and the like) mean
&ldquo;include, without limitation,&rdquo; &ldquo;includes, without limitation,&rdquo; and &ldquo;including, without limitation&rdquo;
(and the like), respectively;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD STYLE="text-align: justify">all references to articles, sections, and exhibits are to articles, sections, and exhibits in or to the
Plan;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(f)</TD><TD STYLE="text-align: justify">all words used will be construed to be of such gender or number as the circumstances and context require;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(g)</TD><TD STYLE="text-align: justify">the captions and headings of articles, sections, and exhibits have been inserted solely for convenience
of reference and will not be considered a part of the Plan, nor will any of them affect the meaning or interpretation of the Plan;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(h)</TD><TD STYLE="text-align: justify">any reference to an agreement, plan, policy, form, document, or set of documents, and the rights and obligations
of the parties under any such agreement, plan, policy, form, document, or set of documents, will mean the agreement, plan, policy, form,
document, or set of documents as amended from time to time, and any and all modifications, extensions, renewals, substitutions, or replacements
thereof; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">all accounting terms not specifically defined will be construed in accordance with GAAP.</TD></TR></TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt; text-align: center"><FONT STYLE="font-size: 10pt">28</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 0in">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>5
<FILENAME>ss2014993_ex1071.htm
<DESCRIPTION>CALCULATION OF FILING FEE TABLE
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: right">Exhibit 107.1</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 5.75pt 6pt 5.05pt; text-align: center"><B>CALCULATION OF FILING FEE TABLE</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 5.75pt 6pt 5.05pt; text-align: center"><B>S-8</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 5.75pt 6pt 5.05pt; text-align: center">(Form Type)</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 5.75pt 6pt 5.05pt; text-align: center"><B>CVS Health Corporation<BR>
</B>(Exact Name of Registrant as Specified in its Charter)</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 5.75pt 6pt 5.05pt; text-align: center"><U>Table 1: Newly Registered Securities</U></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 8%; border: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><B>Security Type</B></TD>
    <TD STYLE="width: 9%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><B>Security Class Title</B></TD>
    <TD STYLE="width: 11%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><B>Fee Calculation Rule</B></TD>
    <TD STYLE="width: 12%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><B>Amount Registered</B></TD>
    <TD STYLE="width: 23%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><B>Proposed Maximum Offering Price Per Unit</B></TD>
    <TD STYLE="width: 14%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><B>Maximum Aggregate Offering Price</B></TD>
    <TD STYLE="width: 11%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><B>Fee Rate</B></TD>
    <TD STYLE="width: 12%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><B>Amount of Registration Fee</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Equity</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Common Stock, $0.01 par value per share </TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Other</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">11,195,630 (1)(2)</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">$72.34 (3)</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">$809,891,874 (3)</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">0.0001102</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">$89,250.08 (3)</TD></TR>
  <TR>
    <TD COLSPAN="4" STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><B>Total Offering Amounts</B></TD>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">$809,891,874</TD>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">$89,250.08</TD></TR>
  <TR>
    <TD COLSPAN="4" STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><B>Total Fee Offsets</B></TD>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">N/A</TD></TR>
  <TR>
    <TD COLSPAN="4" STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><B>Net Fee Due</B></TD>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">$89,250.08</TD></TR>
  </TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in">(1)</TD><TD STYLE="text-align: justify">This Registration Statement on Form S-8 relates to 11,195,630 shares of common stock, par value $0.01
per share (&ldquo;<B>Common Stock</B>&rdquo;), of CVS Health Corporation (the &ldquo;<B>Company</B>&rdquo; or the &ldquo;<B>Registrant</B>&rdquo;).
In connection with the Agreement and Plan of Merger, dated as of February 7, 2023 (the &ldquo;<B>Merger Agreement</B>&rdquo;) by CVS Pharmacy,
Inc. (the &ldquo;<B>Parent</B>&rdquo;), a Rhode Island corporation and wholly-owned subsidiary of the Company, with Oak Street Health,
Inc., a Delaware corporation (&ldquo;<B>Oak Street</B>&rdquo;) and Halo Merger Sub, Inc., a Delaware corporation and wholly-owned subsidiary
of the Parent (the &ldquo;<B>Merger Subsidiary</B>&rdquo;), such shares available for issuance under the Oak Street Health, Inc. Omnibus
Incentive Plan (the &ldquo;<B>Plan</B>&rdquo;) were converted from shares of common stock, par value $0.001 per share, of Oak Street into
shares of Common Stock immediately prior to the effective time of the merger, whereby Oak Street became a wholly-owned subsidiary of the
Company (the &ldquo;<B>Merger</B>&rdquo;), and adjusted pursuant to the Equity Award Exchange Ratio (as defined below) in accordance with
the terms of the Merger Agreement. <FONT STYLE="background-color: white">At the effective time of the Merger,&nbsp;13,877,676 shares of
Oak Street common stock were reserved and available for issuance pursuant to future awards under the Plan.&nbsp;As adjusted for the&nbsp;Equity
Award Exchange Ratio (as defined below), this equates to 7,313,536 shares of Common Stock to be registered hereunder. This Registration
Statement also covers 3,882,094 shares of Common Stock that are subject to awards that were outstanding under the Plan and were assumed
by the Company at the effective time of the Merger and that, pursuant to the terms of the Merger Agreement, were adjusted to take account
of the Equity Award Exchange Ratio. The &ldquo;<B>Equity Award Exchange Ratio</B>&rdquo; is equal to 0.5270, which equals the quotient
of $39.00 divided by the average of the volume weighted averages of the trading prices of a share of Common Stock on the New York Stock
Exchange (the &ldquo;<B>NYSE</B>&rdquo;) on the 10 consecutive trading days ending on April 28, 2023.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in">(2)</TD><TD STYLE="text-align: justify">Pursuant to Rule 416(a) under the Securities Act of 1933 (the &ldquo;<B>Securities Act</B>&rdquo;), this
Registration Statement also covers any additional shares of Common Stock that become issuable under the Plan by any reason of any stock
dividend, stock split, or other similar transaction.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in">(3)</TD><TD STYLE="text-align: justify">Estimated solely for the purpose of calculating the registration fee in accordance with Rule 457(c) and
(h) under the Securities Act based o<FONT STYLE="background-color: white">n a price of $</FONT>72.34 <FONT STYLE="background-color: white">per
share of Common Stock, which is the average of the high and low price per share of Common Stock as reported by the&nbsp;</FONT>NYSE<FONT STYLE="background-color: white">&nbsp;on
April </FONT>26<FONT STYLE="background-color: white">, 2023.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image_01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  , /<# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#9TBPL=%\;
M)_PENG7<>LSZB[6>LB9O+G#,2D9P>!C V].*Z/XE7\NFZUX/NXK6:Z:/47(@
MA^])^Z;@5R.GR7FN?%=O"NJ:E=7>E:9.+V!)"NXR*25W$+R!GI7I'B:RBNO$
M'A>:0N&M[YG3:>"?+8<T#.=\$:I-J_Q+\374UC<6+&TM1]GN/O+C=S^-<]KE
MIIUY\3?$8U'PU?:UL^R^6;9R!#F/G.#W_I7H.EV,47Q$UZ]4OYLUK;JP)XP,
MXQ7$^*KN_P!$\<ZK<:9J%Q;->"$S*H0@[4P.JGU- CN?&^K?V%X#O[J+]W)Y
M AA!/(=L*OZD5A?"LKI<6K>%_M0N?[-F22.3?NW)(@)Y]F#5H^,]-@UR'P_8
M7^][:6]C>6,' DP,X/MFHM,\-:7X=^(2MI,'V6.XL&66%#\C8;(//.?QH&>?
M>+FT5?&_BV34[>[EO52!=/D@9AY<I3 Y!&"3CK7?>(DU"+X,7::F['4%TS$[
M9YW[><GUJMJ7A^RO[WQJ)S*?M4,+-A@-K(I*E>."#6MJ<7]I_"^2*ZD=_.L
MKOGYC\O7ZT"/(]:U>^?X;1>$Q._VNP<R7#9Y-NJB12?KN _"O9KK55T;X=C4
M7;'D:<K#)ZG8,?K7+ZQX5TUK/5[H+(LUQH\-O(P(^Z._3KP*U_%6FPW_ (*T
MW2YGD%M(UO&X4@%E&.#QWH&87PID?2[Z^T.:[%P\]O%J*MYF[#/]\?@<53\7
MZE?Z)\5_[8MF9K.SL(S>Q#O$S;2?PSFNB7PIH_A_QSH]UI%K]C:2.6.1(V.U
MQCN#FM"32;6[\=:A).K.)],$$B'&TKN]* ,SX1SK<^&;^9)/,C?4YV1L]5+9
M%'Q9OO*\-P6,32R375PN;6'.Z>->77CMBKWPWTBVT/P[<65H7\E+R7;O.2.>
ME9OQ;C:R\/P^(;662'4=-?=;R+C'S<$$$<B@"_X!O?#BVC:9X=><PJ@N#$[%
ME@W?P GI@]JVO%EGJ.H>%=1M-*F,5]+"5B8'!SZ9[9KB_AIIZZ7?EX9I7_M.
MT6\N!)MQYAZD8 Q]*[CQ*DDGAV]$5Q-;R",LLL) 92.>,@T@.(^&JZ#9ZE/8
MP:5=Z1K:PC[3;32,5D]7&3@\]ZH>)/!^B3?%O1[=[0F*_@EGN5\QL.X/!ZTO
MPCN;KQ+?7WB'5[J6YO[?-I&QP%6//H!UKK=6T^&;XCZ)?,7\V&VE50#Q@GO3
M Y[XO10BT\-P26DMU;_;MC6T3$-(NW[HKI_ EK96NANECHESI$1E)-O<,2Q/
MKR:ROBA;^98:7=)-)#/:W/FQ/'CAL>X-:7@'4;[4M"DFO[J2YE$Q4.X ./3@
M"@#R/1?L37>G)I$5ZGBF35'9YU9@C0"0[L\X(QVQ7I'Q&9EU3PAAB,ZH,X/7
MY:SHM$MK3P_HUU \RW%IJKM%(&&<.YW*>.0?2M+XH6WFZ?I=RLTD4UK<^;$\
M9'#8]P: .E\6DCP?K)!P?L4O_H)KDXF;_A0>[<=W]C9SGG[E6M#N;O6OAYJ?
M]HW<MP\D<T9D8*&Q@CL *LIIT(^$O]G;G\G^S?+SD;L;: /-K#5[U?\ A$?#
MNJ3%KZPU*)HWR?WT#1DHWOCI^%=IXQ6+7/'MEX?U/SGT:'3I+^:WC8@7#!L
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?8> ]*M8BQCCC8 L<G[[44 ?_V0$!              $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
